[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,805,913,983,1028,1074,1171,1372,1487],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":28,"verifyTime":776,"verifyNote":784,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":785,"fullTextUrl":26,"authors":786,"publicationType":747,"publisherRelationship":787,"citationCount":26,"citationInfo":26,"publishDate":803,"publishYear":804,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"f1ea3096-45fd-4619-a03a-153929dcf569","2023-12-09T22:02:25.273+00:00","2025-01-22T16:58:18.456+00:00",[],"Cirug%C3%ADa-de-los-tumores-epiteliales-malignos-del-ovario",{"title":780,"doi":782},{"EN":781},"Cirugía de los tumores epiteliales malignos del ovario",{"VOID":783},"10.1016\u002FS1283-081X(10)70778-5","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X10707785",[],{"url":785,"publisher":788,"properties":796},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":789,"slug":662,"properties":790,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":793,"manageAffiliations":794,"indexDatabases":795,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":791,"title":792},{"VOID":665},{"EN":667},[],[],[],{"volume":797,"pages":799,"issue":801},{"VOID":798},"46",{"VOID":800},"1-16",{"VOID":802},"1","2010-01-01",2010,{"id":806,"createTime":807,"updateTime":808,"relativeEntities":809,"slug":810,"properties":811,"entityType":688,"verifyStatus":25,"verifyTime":808,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":114,"primaryUrl":818,"fullTextUrl":26,"authors":819,"publicationType":747,"publisherRelationship":897,"citationCount":26,"citationInfo":26,"publishDate":911,"publishYear":912,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"9d67cd16-0f01-466a-aae5-0ce915f778a3","2023-12-07T00:38:49.269+00:00","2025-02-09T19:32:25.739+00:00",[],"Infertilidad-femenina-de-origen-endocrino",{"references":812,"title":814,"doi":816},{"VOID":813},"Ducornet, 2005, Contrôle hypothalamique des sécrétions hormonales antéhypophysaires, EMC Endocrinologie, 2, 209, 10.1016\u002Fj.emcend.2005.08.001\nSmith, 2008, Kisspeptin signalling in the brain: steroid regulation in the rodent and ewe, Brain Res Rev, 57, 288, 10.1016\u002Fj.brainresrev.2007.04.002\nClarkson, 2006, Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons, Endocrinology, 147, 5817, 10.1210\u002Fen.2006-0787\nFranceschini, 2006, Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha, Neurosci Lett, 401, 225, 10.1016\u002Fj.neulet.2006.03.039\nCaraty, 2008, Le système Kisspeptine\u002FGPR54: la clé majeure du contrôle de la reproduction, MT Méd Reprod Gynecol Endocrinol, 10, 114\nRodet, 2008, Le couple kisspeptine\u002FGPR54, un acteur majeur de la régulation neuroendocrine de la reproduction, mt Med Reprod Gynécol Endocrinol, 10, 123\nSchally, 1971, Isolation and properties of the FSH and LH-releasing hormone, Biochem Biophys Res Commun, 43, 393, 10.1016\u002F0006-291X(71)90766-2\nMoriarty, 1973, Adenohypophysis: ultrastructural cytochemistry. A review, J Histochem Cytochem, 21, 855, 10.1177\u002F21.10.855\nKakar, 1992, Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor, Biochem Biophys Res Commun, 189, 289, 10.1016\u002F0006-291X(92)91556-6\nCrowley, 1985, The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women, Recent Prog Horm Res, 41, 473\nClayton, 1989, Gonadotrophin-releasing hormone: its actions and receptors, J Endocrinol, 120, 11, 10.1677\u002Fjoe.0.1200011\nKnobil, 1980, The neuroendocrine control of the menstrual cycle, Recent Prog Horm Res, 36, 53\nKnobil, 1981, Patterns of hypophysiotropic signals and gonadotropin secretion in the rhesus monkey, Biol Reprod, 24, 44, 10.1095\u002Fbiolreprod24.1.44\nWildt, 1981, Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey, Endocrinology, 109, 376, 10.1210\u002Fendo-109-2-376\nPapandreou, 1991, Biological polymorphism and functional domains of pituitary glycoprotein hormones, Ann Endocrinol, 52, 254\nDubest C, Pugeat M. Gonadotrophines hypophysaires, physiologie et exploration fonctionnelle. EMC Endocrinologie 2005;2(4).\nPigny, 1992, Glycoprotein hormones, glycosylation and biological activity, Ann Biol Clin, 50, 557\nSchaison, 1997, Le cycle menstruel humain\nMinegishi, 1990, Cloning and sequencing of human LH\u002FhCG receptor cDNA, Biochem Biophys Res Commun, 172, 1049, 10.1016\u002F0006-291X(90)91552-4\nMinegishi, 1991, Cloning and sequencing of human FSH receptor cDNA, Biochem Biophys Res Commun, 175, 1125, 10.1016\u002F0006-291X(91)91682-3\nDeffieux, 2003, Inhibins, activins and anti-Mullerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine, Gynecol Obstet Fertil, 31, 900, 10.1016\u002Fj.gyobfe.2003.08.012\nKlein, 1996, Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles, J Clin Endocrinol Metab, 81, 2742, 10.1210\u002Fjc.81.7.2742\nChabbert Buffet, 1998, Regulation of the human menstrual cycle, Front Neuroendocrinol, 19, 151, 10.1006\u002Ffrne.1998.0167\nElvin, 1999, Paracrine actions of growth differentiation factor-9 in the mammalian ovary, Mol Endocrinol, 13, 1035, 10.1210\u002Fme.13.6.1035\nHugues, 2005, L’assistance médicale à la procréation : indications, évaluation endocrinienne, Med Clin - Endocrinol Diabete, 14, 39\nFanchin, 2003, Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3, Hum Reprod, 18, 323, 10.1093\u002Fhumrep\u002Fdeg042\nPigny, 2006, Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 941, 10.1210\u002Fjc.2005-2076\nPugeat, 2010, Recommendations for investigation of hyperandrogenism, Ann Endocrinol, 71, 2, 10.1016\u002Fj.ando.2009.12.007\nYoung, 2010, Detection and management of late-onset 21-hydroxylase deficiency in women with hyperandrogenism, Ann Endocrinol, 71, 14, 10.1016\u002Fj.ando.2009.12.009\nNoyes, 1950, Dating the endometrial biopsy, Fertil Steril, 1, 3, 10.1016\u002FS0015-0282(16)30062-0\nMurray, 2004, A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometr1ial dating in fertile women, Fertil Steril, 81, 1333, 10.1016\u002Fj.fertnstert.2003.11.030\nCoutifaris, 2004, Histological dating of timed endometrial biopsy tissue is not related to fertility status, Fertil Steril, 82, 1264, 10.1016\u002Fj.fertnstert.2004.03.069\nSedlmeyer, 2002, Delayed puberty: analysis of a large case series from an academic center, J Clin Endocrinol Metab, 87, 1613, 10.1210\u002Fjc.87.4.1613\nBry-Gauillard, 2010, Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics, Ann Endocrinol, 71, 158, 10.1016\u002Fj.ando.2010.02.024\nRoze, 2009, Congenital hypogonadotropic hypogonadism, Ann Endocrinol, 70, 2, 10.1016\u002Fj.ando.2008.06.005\nHardelin, 2008, The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al, Sex Dev, 2, 181, 10.1159\u002F000152034\nSarfati, 2010, A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes, J Clin Endocrinol Metab, 95, 659, 10.1210\u002Fjc.2009-0843\nde Roux, 1997, A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor, N Engl J Med, 337, 1597, 10.1056\u002FNEJM199711273372205\nBouligand, 2009, Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation, N Engl J Med, 360, 2742, 10.1056\u002FNEJMoa0900136\nde Roux, 2003, Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54, Proc Natl Acad Sci USA, 100, 10972, 10.1073\u002Fpnas.1834399100\nSmith, 2006, Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling, Reproduction, 131, 623, 10.1530\u002Frep.1.00368\nLofrano-Porto, 2007, Luteinizing hormone beta mutation and hypogonadism in men and women, N Engl J Med, 357, 897, 10.1056\u002FNEJMoa071999\nYoung, 2010, TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans, J Clin Endocrinol Metab, 95, 2287, 10.1210\u002Fjc.2009-2600\nBurman, 2001, Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH, Endocr Rev, 22, 787, 10.1210\u002Fer.22.6.787\nSanlaville, 2007, CHARGE syndrome: an update, Eur J Hum Genet, 15, 389, 10.1038\u002Fsj.ejhg.5201778\nOzata, 1999, J Clin Endocrinol Metab, 84, 3686, 10.1210\u002Fjc.84.10.3686\nClement, 1998, A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction, Nature, 392, 398, 10.1038\u002F32911\nStrobel, 1998, A leptin missense mutation associated with hypogonadism and morbid obesity, Nat Genet, 18, 213, 10.1038\u002Fng0398-213\nAchermann, 1999, Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay, J Clin Endocrinol Metab, 84, 4497, 10.1210\u002Fjc.84.12.4497\nChristin-Maitre, 2007, Pregnancy outcomes following pulsatile GnRH treatment: results of a large multicenter retrospective study, J Gynecol Obstet Biol Reprod, 36, 8, 10.1016\u002Fj.jgyn.2006.12.001\nBhangoo, 2009, The genetics of idiopathic hypogonadotropic hypogonadism:unraveling the biology of human sexual development, Pediatr Endocrinol Rev, 6, 395\nFreeman, 2000, Prolactin: structure, function, and regulation of secretion, Physiol Rev, 80, 1523, 10.1152\u002Fphysrev.2000.80.4.1523\nNeville, 1999, Physiology of lactation, Clin Perinatol, 26, 251, 10.1016\u002FS0095-5108(18)30053-8\nTouraine, 2005, Physiologie de la prolactine, EMC-Endocrinologie, 2, 50, 10.1016\u002Fj.emcend.2004.10.002\nCortet-Rudelli, 2007, Etiological diagnosis of hyperprolactinemia, Ann Endocrinol, 68, 98, 10.1016\u002Fj.ando.2007.03.013\nRobin, 2011, Lien physiopathologique entre syndrome des ovaires polymicrokystiques et hyperprolactinémie : mythe ou réalité ?, Gynecol Obstet Fertil, 39, 141, 10.1016\u002Fj.gyobfe.2010.11.002\nCarter, 1977, Adrenocortical function in hyperprolactinemic women, J Clin Endocrinol Metab, 45, 973, 10.1210\u002Fjcem-45-5-973\nHiguchi, 1984, Prolactin has a direct effect on adrenal androgen secretion, J Clin Endocrinol Metab, 59, 714, 10.1210\u002Fjcem-59-4-714\nSchiebinger, 1986, The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects, J Clin Endocrinol Metab, 62, 202, 10.1210\u002Fjcem-62-1-202\nBrue, 2007, Diagnosis and management of hyperprolactinemia: expert consensus - French Society of Endocrinology, Ann Endocrinol, 68, 58, 10.1016\u002Fj.ando.2006.11.001\nBriet, 2009, La pose d’un cathéter intraveineux associée à une période de repos est utile pour le dosage du cortisol, mais ne l’est pas pour le dosage de la prolactine, Ann Endocrinol, 70, e35, 10.1016\u002Fj.ando.2007.03.001\nMounier, 2003, Macroprolactinaemia associated with prolactin adenoma, Hum Reprod, 18, 853, 10.1093\u002Fhumrep\u002Fdeg172\nVallette-Kasic, 2002, Macroprolactinemia revisited: a study on 106 patients, J Clin Endocrinol Metab, 87, 581, 10.1210\u002Fjc.87.2.581\nCastinetti, 2006, Hyperprolactinémie : diagnostic, Med Clin - Endocrinol Diabete, 15, 19\nBazot, 2000, Pathologie fonctionnelle de l’ovaire, J Radiol, 81, 1819\nPhy, 2004, Transvaginal ultrasound detection of multifollicular ovaries in non-hirsute ovulatory women, Ultrasound Obstet Gynecol, 23, 183, 10.1002\u002Fuog.954\nChanson, 2007, Drug treatment of hyperprolactinemia, Ann Endocrinol, 68, 113, 10.1016\u002Fj.ando.2007.03.003\nJan, 2007, Prolactinoma surgery, Ann Endocrinol, 68, 118, 10.1016\u002Fj.ando.2007.03.011\nChristin-Maitre, 2007, Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy, Ann Endocrinol, 68, 106, 10.1016\u002Fj.ando.2007.03.008\nChanson, 2007, Adénomes à prolactine et grossesse\nBrundu, 2006, Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea, J Clin Endocrinol Metab, 91, 1561, 10.1210\u002Fjc.2005-2422\nAndreelli, 2000, Normal reproductive function in leptin-deficient patients with lipoatropic diabetes, J Clin Endocrinol Metab, 85, 715, 10.1210\u002Fjc.85.2.715\nDe Souza, 2004, Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones, J Clin Endocrinol Metab, 89, 3536, 10.1210\u002Fjc.2003-032007\nNavarro, 2005, Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secr1etion in the rat, Endocrinology, 146, 1689, 10.1210\u002Fen.2004-1353\nSeminara, 2005, Metastin and its G protein-coupled receptor. GPR54: critical pathway modulating GnRH secretion, Front Neuroendocrinol, 26, 131, 10.1016\u002Fj.yfrne.2005.10.001\nLaughlin, 1998, Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea, J Clin Endocrinol Metab, 83, 25, 10.1210\u002Fjc.83.1.25\nBansil, 2008, Eating disorders among delivery hospitalizations: prevalence and outcomes, J Womens Health, 17, 1523, 10.1089\u002Fjwh.2007.0779\nBerga, 2006, Use of cognitive behavior therapy for functional hypothalamic amenorrhea, Ann N Y Acad Sci, 1092, 114, 10.1196\u002Fannals.1365.010\nMisra, 2008, What is the best strategy to combat low bone mineral density in functional hypothalamic amenorrhea?, Nat Clin Pract Endocrinol Metab, 4, 542, 10.1038\u002Fncpendmet0925\nMais, 1991, Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone, Fertil Steril, 55, 80, 10.1016\u002FS0015-0282(16)54063-1\nToogood, 2004, Endocrine consequences of brain irradiation, Growth Horm IGF Res, 14, S118, 10.1016\u002Fj.ghir.2004.03.038\nDarzy, 2009, Hypopituitarism following Radiotherapy Revisited, Endocr Dev, 15, 1, 10.1159\u002F000207607\nBirkebaek, 1994, Late endocrine and growth sequelae after cancer treatment in children, Ugeskr Laeger, 156, 4559\nPedersen-Bjergaard, 1996, Pituitary function in hemochromatosis, Ugeskr Laeger, 158, 1818\nValenti, 2009, Association between iron overload and osteoporosis in patients with hereditary hemochromatosis, Osteoporos Int, 20, 549, 10.1007\u002Fs00198-008-0701-4\nLamazou, 2010, Watch out for headaches at the end of a pregnancy! Do not miss an autoimmune hypositys, Gynecol Obstet Fertil, 38, 278, 10.1016\u002Fj.gyobfe.2010.02.006\nAgha, 2004, Anterior pituitary dysfunction in survivors of traumatic brain injury, J Clin Endocrinol Metab, 89, 4929, 10.1210\u002Fjc.2004-0511\nKaravitaki, 2006, Craniopharyngiomas, Endocr Rev, 27, 371, 10.1210\u002Fer.2006-0002\nBonneville, 2003, Rathke's cleft cyst, J Neuroradiol, 30, 238\nFranks, 1995, Polycystic ovary syndrome, N Engl J Med, 333, 853, 10.1056\u002FNEJM199509283331307\nStrauss, 1999, Molecular mysteries of polycystic ovary syndrome, Mol Endocrinol, 13, 800, 10.1210\u002Fme.13.6.800\nWickenheisser, 2000, Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells, J Clin Endocrinol Metab, 85, 2304, 10.1210\u002Fjc.85.6.2304\nWickenheisser, 2005, Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 1720, 10.1210\u002Fjc.2004-1860\nEagleson, 2000, Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone, J Clin Endocrinol Metab, 85, 4047, 10.1210\u002Fjc.85.11.4047\nAnttila, 1991, Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease, Fertil Steril, 55, 1057, 10.1016\u002FS0015-0282(16)54352-0\nDunaif, 1997, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis, Endocr Rev, 18, 774, 10.1210\u002Fer.18.6.774\nWebber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016\u002FS0140-6736(03)14410-8\nFranks, 1998, Etiology of anovulation in polycystic ovary syndrome, Steroids, 63, 306, 10.1016\u002FS0039-128X(98)00035-X\nvan Dessel, 1996, Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen, Hum Reprod, 11, 478, 10.1093\u002FHUMREP\u002F11.3.478\nGiudice, 1999, Growth factor action on ovarian function in polycystic ovary syndrome, Endocrinol Metab Clin North Am, 28, 325, 10.1016\u002FS0889-8529(05)70072-4\nDunaif, 1995, Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome, J Clin Invest, 96, 801, 10.1172\u002FJCI118126\nAmato, 2004, The genetics of polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, 18, 707, 10.1016\u002Fj.bpobgyn.2004.05.002\nUrbanek, 2005, Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2, J Clin Endocrinol Metab, 90, 6623, 10.1210\u002Fjc.2005-0622\nRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.\nFerriman, 1961, Clinical assessment of body hair growth in women, J Clin Endocrinol Metab, 21, 1440, 10.1210\u002Fjcem-21-11-1440\nChang, 2005, Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups, Fertil Steril, 83, 1717, 10.1016\u002Fj.fertnstert.2005.01.096\nMiller, 2004, Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods, J Clin Endocrinol Metab, 89, 525, 10.1210\u002Fjc.2003-030680\nNelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarian theca cells, Endocrinology, 145, 799, 10.1210\u002Fen.2003-0940\nConsensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462–77.\nMessinis, 1997, Current and future status of ovulation induction in polycystic ovary syndrome, Hum Reprod Update, 3, 235, 10.1093\u002Fhumupd\u002F3.3.235\nFernandez, 2001, Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery, Fertil Steril, 75, 607, 10.1016\u002FS0015-0282(00)01746-5\nNorman, 2002, The role of lifestyle modification in polycystic ovary syndrome, Trends Endocrinol Metab, 13, 251, 10.1016\u002FS1043-2760(02)00612-4\nCostello, 2006, A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome, Hum Reprod, 21, 1387, 10.1093\u002Fhumrep\u002Fdei501\nGlueck, 2004, Hum Reprod, 19, 510, 10.1093\u002Fhumrep\u002Fdeh109\nDuranteau, 2010, Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?, Ann Endocrinol, 71, 25, 10.1016\u002Fj.ando.2009.12.005\nGoswami, 2005, Premature ovarian failure, Hum Reprod Update, 11, 391, 10.1093\u002Fhumupd\u002Fdmi012\nBachelot, 2009, Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure, Eur J Endocrinol, 161, 179, 10.1530\u002FEJE-09-0231\nKnauff, 2009, Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure, J Clin Endocrinol Metab, 94, 786, 10.1210\u002Fjc.2008-1818\nChristin-Maitre, 2006, Premature ovarian failure, Ann Endocrinol, 67, 557, 10.1016\u002FS0003-4266(06)73007-4\nNelson, 2005, An update: spontaneous premature ovarian failure is not an early menopause, Fertil Steril, 83, 1327, 10.1016\u002Fj.fertnstert.2004.11.059\nCoulam, 1986, Incidence of premature ovarian failure, Obstet Gynecol, 67, 604\nde Bruin, 2001, The role of genetic factors in age at natural menopause, Hum Reprod, 16, 2014, 10.1093\u002Fhumrep\u002F16.9.2014\nvan Dooren, 2009, Premature ovarian failure and gene polymorphisms, Curr Opin Obstet Gynecol, 21, 313, 10.1097\u002FGCO.0b013e32832e0813\nCabrol, 2007, Turner syndrome, Ann Endocrinol, 68, 2, 10.1016\u002Fj.ando.2006.12.002\nSingh, 1966, The anatomy and histology of XO human embryos and fetuses, Anat Rec, 155, 369, 10.1002\u002Far.1091550309\nPasquino, 1997, Spontaneous pubertal development in Turner's syndrome, J Clin Endocrinol Metab, 82, 1810, 10.1210\u002Fjc.82.6.1810\nOtter, 2010, Triple X syndrome: a review of the literature, Eur J Hum Genet, 18, 265, 10.1038\u002Fejhg.2009.109\nTharapel, 1993, Deletion (X)(q26.1-->q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions, Am J Hum Genet, 52, 463\nPowell, 1994, Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature, Am J Med Genet, 52, 19, 10.1002\u002Fajmg.1320520105\nSullivan, 2005, Association of FMR1 repeat size with ovarian dysfunction, Hum Reprod, 20, 402, 10.1093\u002Fhumrep\u002Fdeh635\nMurray, 1999, Microdeletions in FMR2 may be a significant cause of premature ovarian failure, J Med Genet, 36, 767, 10.1136\u002Fjmg.36.10.767\nDi Pasquale, 2004, Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene, Am J Hum Genet, 75, 106, 10.1086\u002F422103\nSchmidt, 2004, The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance, Development, 131, 933, 10.1242\u002Fdev.00969\nDe Baere, 2003, FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation, Am J Hum Genet, 72, 478, 10.1086\u002F346118\nAittomaki, 1995, Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, 82, 959, 10.1016\u002F0092-8674(95)90275-9\nRubio-Gozalbo, 2010, Gonadal function in male and female patients with classic galactosemia, Hum Reprod Update, 16, 177, 10.1093\u002Fhumupd\u002Fdmp038\nMarlin, 2008, Perrault syndrome: report of four new cases, review and exclusion of candidate genes, Am J Med Genet A, 146A, 661, 10.1002\u002Fajmg.a.32180\nFogli, 2004, Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure, BMC Womens Health, 4, 8, 10.1186\u002F1472-6874-4-8\nDonnez, 2006, Ovarian tissue cryopreservation and transplantation: a review, Hum Reprod Update, 12, 519, 10.1093\u002Fhumupd\u002Fdml032\nTao, 2008, Human oocyte and ovarian tissue cryopreservation and its application, J Assist Reprod Genet, 25, 287, 10.1007\u002Fs10815-008-9236-z\nMorrison, 1975, Mumps oophoritis: a cause of premature menopause, Fertil Steril, 26, 655, 10.1016\u002FS0015-0282(16)41233-1\nMatikainen, 2002, Ligand activation of the aromatic hydrocarbon receptor transcription factor drives Bax-dependent apoptosis in developing fetal ovarian germ cells, Endocrinology, 143, 615, 10.1210\u002Fen.143.2.615\nSharara, 1998, Environmental toxicants and female reproduction, Fertil Steril, 70, 613, 10.1016\u002FS0015-0282(98)00253-2\nMeduri, 2002, Follicle-stimulating hormone receptors in oocytes?, J Clin Endocrinol Metab, 87, 2266, 10.1210\u002Fjc.87.5.2266\nDavis, 2010, The psychosocial transition associated with spontaneous 46. XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health, Fertil Steril, 93, 2321, 10.1016\u002Fj.fertnstert.2008.12.122\nBosze, 2006, Hormone replacement and the risk of breast cancer in Turner's syndrome, N Engl J Med, 355, 2599, 10.1056\u002FNEJMc062795\nZuckerman-Levin, 2009, Androgen replacement therapy in Turner syndrome: a pilot study, J Clin Endocrinol Metab, 94, 4820, 10.1210\u002Fjc.2009-0514\nvan Kasteren, 1999, Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy, Hum Reprod Update, 5, 483, 10.1093\u002Fhumupd\u002F5.5.483\nCabanes, 2010, Turner syndrome and pregnancy: clinical practice. Recommendations for the management of patients with Turner syndrome before and during pregnancy, Eur J Obstet Gynecol Reprod Biol, 152, 18, 10.1016\u002Fj.ejogrb.2010.05.019\nDolmans, 2009, IVF outcome in patients with orthotopically transplanted ovarian tissue, Hum Reprod, 24, 2778, 10.1093\u002Fhumrep\u002Fdep289\nBorgstrom, 2009, Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles, J Clin Endocrinol Metab, 94, 74, 10.1210\u002Fjc.2008-0708\nDewailly, 2002, Nonclassic 21-hydroxylase deficiency, Semin Reprod Med, 20, 243, 10.1055\u002Fs-2002-35388\nDewailly, 2005, Les formes non classiques du déficit en 21-hydroxylase, Med Clin - Endocrinol Diabète, 14, 57\nBidet, 2010, Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 95, 1182, 10.1210\u002Fjc.2009-1383\nHolmes-Walker, 1995, Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Clin Endocrinol, 43, 291, 10.1111\u002Fj.1365-2265.1995.tb02034.x\nMoran, 2006, Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia, J Clin Endocrinol Metab, 91, 3451, 10.1210\u002Fjc.2006-0062\nFeldman, 1992, Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 74, 635, 10.1210\u002Fjc.74.3.635\nBidet, 2009, Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members, J Clin Endocrinol Metab, 94, 1570, 10.1210\u002Fjc.2008-1582\nMorel, 2003, 21 hydroxylase deficiency: new strategies emerging from molecular studies, Ann Endocrinol, 64, 456\nTardy, 2004, Conseil génétique et conduite à tenir avant, pendant et après la grossesse en cas de bloc surrénalien en 21-hydroxylase, Med Thér - Endocrinol Reprod, 6, 281",{"ES":815},"Infertilidad femenina de origen endocrino",{"VOID":817},"10.1016\u002Fs1283-081x(12)63398-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X12633980",[820,837,849,861,873,885],{"id":821,"sortIndex":114,"researcher":26,"roles":822,"affiliations":823,"properties":834},"08bfa28a-d1e9-42f2-ba25-27c2778f08b7",[696],[824],{"id":26,"sortIndex":36,"affiliation":825,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":829,"slug":830,"properties":831,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0062ad72-389d-448d-9bf9-e0ae54fc3bf9","2023-12-07T00:38:49.290+00:00","2025-06-11T13:53:12.064+00:00",[],"Service-de-gyn%C3%A9cologie-endocrinienne-et-m%C3%A9decine-de-la-reproduction-H%C3%B4pital-Jeanne-de-Flandre-CHRU-avenue-Eug%C3%A8ne-Avin%C3%A9e-59037-Lille-cedex-France",{"title":832},{"VI":833},"Service de gynécologie endocrinienne et médecine de la reproduction, Hôpital Jeanne de Flandre CHRU, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":835},{"VI":836},"C. Proust-Richard",{"id":838,"sortIndex":36,"researcher":26,"roles":839,"affiliations":840,"properties":846},"995c9266-1464-4ec5-b22b-0dde714c2e77",[696],[841],{"id":26,"sortIndex":36,"affiliation":842,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":843,"slug":830,"properties":844,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":845},{"VI":833},{"title":847},{"VI":848},"G. Robin",{"id":850,"sortIndex":59,"researcher":26,"roles":851,"affiliations":852,"properties":858},"376a2fad-c303-44ae-a363-8b3f484cca6b",[696],[853],{"id":26,"sortIndex":36,"affiliation":854,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":855,"slug":830,"properties":856,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":857},{"VI":833},{"title":859},{"VI":860},"W. Karouz",{"id":862,"sortIndex":115,"researcher":26,"roles":863,"affiliations":864,"properties":870},"604606c2-e627-4d7a-8ef1-bfa0ee2f6153",[696],[865],{"id":26,"sortIndex":36,"affiliation":866,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":867,"slug":830,"properties":868,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":869},{"VI":833},{"title":871},{"VI":872},"C. Ferte-Delbende",{"id":874,"sortIndex":162,"researcher":26,"roles":875,"affiliations":876,"properties":882},"af8ad92e-8a86-4990-b199-ebd9d6bfe0bd",[696],[877],{"id":26,"sortIndex":36,"affiliation":878,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":879,"slug":830,"properties":880,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":881},{"VI":833},{"title":883},{"VI":884},"S. Catteau-Jonard",{"id":886,"sortIndex":111,"researcher":26,"roles":887,"affiliations":888,"properties":894},"a8576717-bfc5-4e02-8471-5c46ed478df5",[696],[889],{"id":26,"sortIndex":36,"affiliation":890,"properties":26},{"id":826,"createTime":827,"updateTime":828,"relativeEntities":891,"slug":830,"properties":892,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":893},{"VI":833},{"title":895},{"VI":896},"D. Dewailly",{"url":818,"publisher":898,"properties":906},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":899,"slug":662,"properties":900,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":903,"manageAffiliations":904,"indexDatabases":905,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":901,"title":902},{"VOID":665},{"EN":667},[],[],[],{"volume":907,"pages":909},{"VOID":908},"48",{"VOID":910},"1-28","2012-12-01",2012,{"id":914,"createTime":915,"updateTime":916,"relativeEntities":917,"slug":918,"properties":919,"entityType":688,"verifyStatus":25,"verifyTime":916,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":926,"fullTextUrl":26,"authors":927,"publicationType":747,"publisherRelationship":967,"citationCount":26,"citationInfo":26,"publishDate":981,"publishYear":982,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b01aff45-1715-4944-8358-bf5ecf6e69ef","2024-01-12T04:08:28.664+00:00","2024-12-05T23:50:18.874+00:00",[],"Recidiva-locorregional-del-c%C3%A1ncer-de-mama",{"references":920,"title":922,"doi":924},{"VOID":921},"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. 2019. https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaineentre-1990-et-2018-volume-1-tumeurs-solides-etud.\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies: incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nClemons, 2001, Locoregionally recurrent breast cancer: incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer: results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for earlystage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nMannino, 2009, Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?, Radiotherapy and Oncology, 90, 14, 10.1016\u002Fj.radonc.2008.05.002\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and Doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nMeattini, 2017, Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: long-term experience from two large-institutional series, Breast, 33, 139, 10.1016\u002Fj.breast.2017.03.017\nTay, 2020, Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors, Breast J, 26, 937, 10.1111\u002Ftbj.13738\nWu, 2020, Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ, Ann Surg Oncol, 27, 1627, 10.1245\u002Fs10434-019-08184-z\nMarinovich, 2016, The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 23, 3811, 10.1245\u002Fs10434-016-5446-2\nSigal-Zafrani, 2004, Histological margin assessment for breast ductal carcinoma in situ: precision and implications, Mod Pathol, 17, 81, 10.1038\u002Fmodpathol.3800019\nvan la Parra, 2019, Oncoplastic level 2 mammoplasty for large DCIS: 5-year results, Ann Surg Oncol, 26, 2459, 10.1245\u002Fs10434-019-07423-7\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a followup study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nKimberly, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year followup of a randomised, controlled phase 3 trial, Lancet Oncol, 19, 1385, 10.1016\u002FS1470-2045(18)30380-2\nde Boniface, 2017, Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 17, 379, 10.1186\u002Fs12885-017-3361-y\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is ‘young’?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWapnir, 2018, Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial, J Clin Oncol, 36, 1073, 10.1200\u002FJCO.2017.76.5719\nPan, 2017, 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years, N Engl J Med, 377, 1836, 10.1056\u002FNEJMoa1701830\nLowery, 2012, Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype, Breast Cancer Res Treat, 133, 831, 10.1007\u002Fs10549-011-1891-6\nZumsteg, 2013, Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer, Ann Surg Oncol, 20, 3469, 10.1245\u002Fs10434-013-3011-9\nChen, 2017, Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv Radiat Oncol, 2, 105, 10.1016\u002Fj.adro.2017.01.012\nWang, 2010, Triplenegative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nMamounas, 2010, Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20, J Clin Oncol, 28, 1677, 10.1200\u002FJCO.2009.23.7610\nMamounas, 2017, 21-Gene recurrence score and locoregional recurrence in nodepositive\u002Fer-positive breast cancer treated with chemo-endocrine therapy, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjw259\nTurashvili, 2017, 21-Gene recurrence score and locoregional recurrence in lymph nodenegative, estrogen receptor-positive breast cancer, Breast Cancer Res Treat, 166, 69, 10.1007\u002Fs10549-017-4381-7\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nAziz, 2006, The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer, Breast J, 12, 331, 10.1111\u002Fj.1075-122X.2006.00271.x\nChagpar, 2004, Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique, Am J Surg, 188, 399, 10.1016\u002Fj.amjsurg.2004.06.020\nMoore, 2000, Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy, Ann Surg, 231, 877, 10.1097\u002F00000658-200006000-00012\nvan Deurzen, 2016, Predictors of surgical margin following breastconserving surgery: a large population-based cohort study, Ann Surg Oncol, 23, 627, 10.1245\u002Fs10434-016-5532-5\nPleijhuis, 2013, A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making, Breast, 22, 773, 10.1016\u002Fj.breast.2013.01.010\nHeil, 2012, Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study, Ann Surg Oncol, 19, 541, 10.1245\u002Fs10434-011-1947-1\nGagliato Dde, 2014, Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer, J Clin Oncol, 32, 735, 10.1200\u002FJCO.2013.49.7693\nHennigs, 2016, Do patients after reexcision due to involved or close margins have the same risk of local recurrence as those after one-step breast-conserving surgery?, Ann Surg Oncol, 23, 1831, 10.1245\u002Fs10434-015-5067-1\nHolland, 1985, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer, 56, 979, 10.1002\u002F1097-0142(19850901)56:5\u003C979::AID-CNCR2820560502>3.0.CO;2-N\nFitzgerald, 2016, Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery, Ann Surg Oncol, 23, 4270, 10.1245\u002Fs10434-016-5490-y\nGarvey, 2015, Rates of residual disease with close but negative margins in breast cancer surgery, Breast, 24, 413, 10.1016\u002Fj.breast.2015.03.005\nDemirci, 2012, Breast conservation therapy: the influence of molecular subtype and margins, Int J Radiation Oncol Biol Physics, 83, 814, 10.1016\u002Fj.ijrobp.2011.09.001\nJones, 2009, Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial, J Clin Oncol, 27, 4939, 10.1200\u002FJCO.2008.21.5764\nHoussami, 2014, The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 21, 717, 10.1245\u002Fs10434-014-3480-5\nMoran, 2014, Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer, J Clin Oncol, 32, 1507, 10.1200\u002FJCO.2013.53.3935\nVaidya, 2020, Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial, BMJ, 370\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nBroecker, 2017, Neoadjuvant therapy combined with oncoplastic reduction for high-stage breast cancer patients, Ann Plast Surg, 78, S258, 10.1097\u002FSAP.0000000000001062\nMazouni, 2013, The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy, Breast, 22, 1189, 10.1016\u002Fj.breast.2013.07.055\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Cancer, 27, 240\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local recurrence after breast conservation (BORST), Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nSellam, 2019, Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment, Breast J, 25, 619, 10.1111\u002Ftbj.13290\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nHannoun-Levi, 2011, Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction, Brachytherapy, 10, 171, 10.1016\u002Fj.brachy.2010.05.004\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy. a second chance to preserve the breast1, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nVavassori, 2020, High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study, J Contemp Brachytherapy, 12, 207, 10.5114\u002Fjcb.2020.96860\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nMaaskant-Braat, 2013, Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature, Breast Cancer Res Treat, 138, 13, 10.1007\u002Fs10549-013-2409-1\nVugts, 2015, Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer, Ann Surg Oncol, 22, S529, 10.1245\u002Fs10434-015-4787-6\nVugts, 2015, Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer, Breast Cancer Res Treat, 153, 549, 10.1007\u002Fs10549-015-3571-4\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nRauschecker, 2001, Systemic therapy for treating locoregional recurrence in women with breast cancer, Cochrane Database Syst Rev, CD002195\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347",{"ES":923},"Recidiva locorregional del cáncer de mama",{"VOID":925},"10.1016\u002Fs1283-081x(22)46718-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2246718X",[928,943,955],{"id":929,"sortIndex":115,"researcher":26,"roles":930,"affiliations":931,"properties":940},"5635d257-5426-4a90-918d-397a90d7f98a",[696],[932],{"id":26,"sortIndex":36,"affiliation":933,"properties":26},{"id":934,"createTime":935,"updateTime":935,"relativeEntities":936,"slug":26,"properties":937,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a40fbfc9-f226-4942-b18d-08639538be21","2024-01-12T04:08:28.851+00:00",[],{"title":938},{"VI":939},"Département de chirurgie oncologique, ICM Val d’Aurelle, rue de la Croix-Verte, 34298 Montpellier, France",{"title":941},{"VI":942},"C. Taoum",{"id":944,"sortIndex":36,"researcher":26,"roles":945,"affiliations":946,"properties":952},"088b5668-ccf2-4ccc-9e1f-710a39ebbf98",[696],[947],{"id":26,"sortIndex":36,"affiliation":948,"properties":26},{"id":934,"createTime":935,"updateTime":935,"relativeEntities":949,"slug":26,"properties":950,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":951},{"VI":939},{"title":953},{"VI":954},"P.-E. Colombo",{"id":956,"sortIndex":114,"researcher":26,"roles":957,"affiliations":958,"properties":964},"997809e6-5134-4187-8c55-2df934ca2a6c",[696],[959],{"id":26,"sortIndex":36,"affiliation":960,"properties":26},{"id":934,"createTime":935,"updateTime":935,"relativeEntities":961,"slug":26,"properties":962,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":963},{"VI":939},{"title":965},{"VI":966},"P. Rouanet",{"url":926,"publisher":968,"properties":976},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":969,"slug":662,"properties":970,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":973,"manageAffiliations":974,"indexDatabases":975,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":971,"title":972},{"VOID":665},{"EN":667},[],[],[],{"volume":977,"pages":979},{"VOID":978},"58",{"VOID":980},"1-20","2022-07-01",2022,{"id":984,"createTime":985,"updateTime":986,"relativeEntities":987,"slug":988,"properties":989,"entityType":688,"verifyStatus":25,"verifyTime":996,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":997,"fullTextUrl":26,"authors":998,"publicationType":747,"publisherRelationship":1014,"citationCount":26,"citationInfo":26,"publishDate":1027,"publishYear":912,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4e38148a-9f6c-4f79-9b45-71ff71403690","2024-02-08T19:10:08.624+00:00","2025-01-14T13:28:44.322+00:00",[],"Pubertad-precoz",{"references":990,"title":992,"doi":994},{"VOID":991},"Zacharias, 1976, A prospective study of sexual development in American girls: the statistic of menarche, Obstet Gynecol Surv, 31, 325, 10.1097\u002F00006254-197604000-00026\nHerman-Giddens, 1997, Secondary sexual characteristics and menses in young girls seen in office practise: a study from the Pediatric Research in Office Settings network, Pediatrics, 99, 505, 10.1542\u002Fpeds.99.4.505\nWyshak, 1982, Evidence for a secular trend in age of menarche, N Engl J Med, 306, 1033, 10.1056\u002FNEJM198204293061707\nWhincup, 2001, Age of menarche in contempory British teenagers: survey of girls born between 1982 and 1986, Br Med J, 322, 1095, 10.1136\u002Fbmj.322.7294.1095\nKrstevska-Konstantinova, 2001, Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides, Hum Reprod, 16, 1020, 10.1093\u002Fhumrep\u002F16.5.1020\nZacharias, 1969, Age at menarche, N Engl J Med, 280, 868, 10.1056\u002FNEJM196904172801606\nCarel, 2009, Consensus statement on the use of gonadotropin-releasing hormone analogs in children, Pediatrics, 123, e752, 10.1542\u002Fpeds.2008-1783\nCarel, 2008, Clinical practice. Precocious puberty, N Engl J Med, 358, 2366, 10.1056\u002FNEJMcp0800459\nde Vries, 2010, Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty, J Pediatr, 156, 466, 10.1016\u002Fj.jpeds.2009.09.071\nde Vries, 2006, Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche, Eur J Endocrinol, 154, 891, 10.1530\u002Feje.1.02151\nStanhope, 2003, Gonadotrophin-dependent [correction of dependant] precocious puberty and occult intracranial tumors: which girls should have neuro-imaging?, J Pediatr, 143, 426, 10.1067\u002FS0022-3476(03)00492-X\nChalumeau, 2003, Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule, J Pediatr, 143, 445, 10.1067\u002FS0022-3476(03)00328-7\nVirdis, 1998, Precocious puberty in girls adopted from developing countries, Arch Dis Child, 78, 152, 10.1136\u002Fadc.78.2.152\nKalfa, 2009, Juvenile ovarian granulosa cell tumor: a benign or malignant condition?, Gynecol Endocrinol, 25, 299, 10.1080\u002F09513590802630153\nBrauner, 2010, Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls, PLoS One, 5, e11282, 10.1371\u002Fjournal.pone.0011282\nVölkl, 2006, McCune-Albright syndrome: clinical picture and natural history in children and adolescents, J Pediatr Endocrinol Metab, 19, 551, 10.1515\u002FJPEM.2006.19.S2.551\nMieszczak, 2008, The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome, J Clin Endocrinol Metab, 93, 2751, 10.1210\u002Fjc.2007-2090\nBeas, 1969, Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens, J Pediatr, 75, 127, 10.1016\u002FS0022-3476(69)80113-7\nGhazi, 1994, Oestrogen and cortisol producing adrenal tumour, Arch Dis Child, 71, 358, 10.1136\u002Fadc.71.4.358\nCarel, 1999, Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment, J Clin Endocrinol Metab, 84, 1973, 10.1210\u002Fjc.84.6.1973\nHeger, 2006, Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function, Mol Cell Endocrinol, 254, 217, 10.1016\u002Fj.mce.2006.04.012\nBouvattier, 1999, Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study, J Clin Endocrinol Metab, 84, 3575, 10.1210\u002Fjc.84.10.3575\nBlanco-Garcia, 1985, Isolated menses in prepubertal girls, Pediatrics, 76, 43, 10.1542\u002Fpeds.76.1.43\nTumini, 2010, Genital sanguineous discharge in prepuberty: a case of mullerian papilloma of vagina in a nine-year-old girl, J Pediatr Endocrinol Metab, 23, 831, 10.1515\u002Fjpem.2010.133",{"ES":993},"Pubertad precoz",{"VOID":995},"10.1016\u002Fs1283-081x(12)62739-8","2025-01-14T13:28:44.321+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X12627398",[999],{"id":1000,"sortIndex":36,"researcher":26,"roles":1001,"affiliations":1002,"properties":1011},"7070dd66-00e7-4c58-ba08-71d260c75f0b",[696],[1003],{"id":26,"sortIndex":36,"affiliation":1004,"properties":26},{"id":1005,"createTime":1006,"updateTime":1006,"relativeEntities":1007,"slug":26,"properties":1008,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2daa899d-7642-4e78-8a97-99f24bfff10b","2024-02-08T19:10:08.640+00:00",[],{"title":1009},{"VI":1010},"Service d’endocrinologie pédiatrique, Hôpital Bicêtre, Université Paris Descartes, 78, rue du Général-Leclerc, 94270, Le Kremlin-Bicêtre, France",{"title":1012},{"VI":1013},"C. Bouvattier",{"url":997,"publisher":1015,"properties":1023},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1016,"slug":662,"properties":1017,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1020,"manageAffiliations":1021,"indexDatabases":1022,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1018,"title":1019},{"VOID":665},{"EN":667},[],[],[],{"volume":1024,"pages":1025},{"VOID":908},{"VOID":1026},"1-5","2012-09-01",{"id":1029,"createTime":1030,"updateTime":1031,"relativeEntities":1032,"slug":1033,"properties":1034,"entityType":688,"verifyStatus":25,"verifyTime":1031,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1041,"fullTextUrl":26,"authors":1042,"publicationType":747,"publisherRelationship":1058,"citationCount":26,"citationInfo":26,"publishDate":1072,"publishYear":1073,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"dd1e0a89-b961-4079-b542-0bd7b4a1267d","2023-12-22T02:43:48.784+00:00","2025-02-27T00:59:40.992+00:00",[],"Estudio-del-electrocardiograma-fetal",{"references":1035,"title":1037,"doi":1039},{"VOID":1036},"Amer-Wahlin, 2001, Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum monitoring: a Swedish randomised controlled trial, Lancet, 358, 534, 10.1016\u002FS0140-6736(01)05703-8\nGreene, 1987, The ECG waveform, Baillères Clin Obstet Gynaecol, 1, 131, 10.1016\u002FS0950-3552(87)80027-5\nGreene, 1994, The ST waveform, 388\nJenkins, 1986, Can fetal electrocardiography improve the prediction of intrapartum fetal acidosis?, Br J Obstet Gynaecol, 93, 6, 10.1111\u002Fj.1471-0528.1986.tb07804.x\nKeunen, 2000, The PR interval-fetal heart rate relationship during repetitive umbilical cord occlusions in immature fetal sheep, Eur J Obstet Gynecol Reprod Biol, 89, 69, 10.1016\u002FS0301-2115(99)00160-8\nLilja, 1985, ST waveform changes of the fetal electrocardiogram during labour: a clinical entity, Br J Obstet Gynaecol, 92, 611, 10.1111\u002Fj.1471-0528.1985.tb01400.x\nNoren, 2003, Fetal electrocardiography in labor and neonatal outcome: data from the Swedish Randomized Controlled Trial on intrapartum fetal monitoring, Am J Obstet Gynecol, 188, 183, 10.1067\u002Fmob.2003.109\nReed, 1996, The potential impact of PR interval analysis of the fetal electrocardiogram (FECG) on intrapartum fetal monitoring, Eur J Obstet Gynecol Reprod Biol, 68, 87, 10.1016\u002F0301-2115(96)02496-7\nRosen, 1992, Clinical validity of fetal ECG waveform analysis, 95\nSkillern, 1994, A comparative study of the fetal electrocardiogram recorded by the STAN and Nottingham systems, Br J Obstet Gynaecol, 101, 582, 10.1111\u002Fj.1471-0528.1994.tb13647.x\nStrachan, 2000, Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial, Lancet, 355, 456, 10.1016\u002FS0140-6736(99)04373-1\nSymonds, 1994, The P wave and the PR interval, 381\nVan Wijngaarden, 2000, Improving intrapartum surveillance: an individualised T\u002FQRS ratio?, Eur J Obstet Gynecol Reprod Biol, 88, 43, 10.1016\u002FS0301-2115(99)00119-0\nVayssière, 2002, Surveillance de l'ECG foetal pendant le travail, 37\nWestgate, 1992, Randomized trial of cardiotocogram alone or with ST analysis for intrapartum monitoring, Lancet, 340, 194, 10.1016\u002F0140-6736(92)90465-F\nWhittle, 2000, Is it time to abandon cardiotocographic analysis?, Lancet, 355, 422, 10.1016\u002FS0140-6736(00)82002-4",{"ES":1038},"Estudio del electrocardiograma fetal",{"VOID":1040},"10.1016\u002Fs1283-081x(04)70228-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X04702283",[1043],{"id":1044,"sortIndex":36,"researcher":26,"roles":1045,"affiliations":1046,"properties":1055},"ac7c0576-5f9e-4a2d-9724-a8540bc8e6f0",[696],[1047],{"id":26,"sortIndex":36,"affiliation":1048,"properties":26},{"id":1049,"createTime":1050,"updateTime":1050,"relativeEntities":1051,"slug":26,"properties":1052,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"40a82849-6e47-48ae-b89d-4c0c769af739","2023-12-22T02:43:48.826+00:00",[],{"title":1053},{"VI":1054},"Service de gynécologie–obstétrique, Centre hospitalo-universitaire, 4, rue Larrey, 49033 Angers cedex 01, France",{"title":1056},{"VI":1057},"A. Fournié",{"url":1041,"publisher":1059,"properties":1067},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1060,"slug":662,"properties":1061,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1064,"manageAffiliations":1065,"indexDatabases":1066,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1062,"title":1063},{"VOID":665},{"EN":667},[],[],[],{"volume":1068,"pages":1070},{"VOID":1069},"40",{"VOID":1071},"1-3","2004-01-01",2004,{"id":1075,"createTime":1076,"updateTime":1077,"relativeEntities":1078,"slug":1079,"properties":1080,"entityType":688,"verifyStatus":25,"verifyTime":1077,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1087,"fullTextUrl":26,"authors":1088,"publicationType":747,"publisherRelationship":1155,"citationCount":26,"citationInfo":26,"publishDate":1169,"publishYear":1170,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"3508bac7-e92f-497c-adac-82144d89eaa7","2024-02-11T12:25:08.493+00:00","2025-02-14T09:15:31.191+00:00",[],"Miomectom%C3%ADa-mediante-laparotom%C3%ADa",{"references":1081,"title":1083,"doi":1085},{"VOID":1082},"Acién, 1996, Abdominal myomectomy: results of a single operative technique, Fertil. Steril., 65, 41, 10.1016\u002FS0015-0282(16)58025-X\nRoth, 2003, Effects of race and clinical factors on short-term outcomes of abdominal myomectomy, Obstet. Gynecol., 101, 881, 10.1016\u002FS0029-7844(03)00015-2\nLethaby, 2002, Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review, Br. J. Obstet. Gynaecol., 109, 1097, 10.1111\u002Fj.1471-0528.2002.01225.x\nFarquhar, 2002, Cost effectiveness of pre-operarive gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy, Br. J. Obstet. Gynaecol., 109, 1273, 10.1046\u002Fj.1471-0528.2002.01224.x\nCelik, 2003, Use of a single preoperative dose of misoprostol is efficacious for patients who endergo abdominal myomectomy, Fertil. Steril., 79, 1207, 10.1016\u002FS0015-0282(03)00076-1\nFletcher, 1996, A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy, Obstet. Gynecol., 87, 1014, 10.1016\u002F0029-7844(96)00071-3\nLiu, 2004, Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids, Fertil. Steril., 82, 205, 10.1016\u002Fj.fertnstert.2004.01.026\nRoman, 2004, Myomectomy at time of cesarean delivery, BMC Pregnancy Childbirth, 4, 14, 10.1186\u002F1471-2393-4-14\nDiZerega, 2002, A randomized, controlled pilot study for the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery, Hum. Reprod., 17, 1031, 10.1093\u002Fhumrep\u002F17.4.1031\nIverson, 1996, Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas, Obstet. Gynecol., 88, 415, 10.1016\u002F0029-7844(96)00218-9\nLamorte, 1993, Morbidity associated with abdominal myomectomy, Obstet. Gynecol., 82, 897\nSawin, 2000, Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas, Am. J. Obstet. Gynecol., 183, 1448, 10.1067\u002Fmob.2000.107730\nTulandi, 1993, Adhesion formation and reproductive outcome after myomectomy and second look laparoscopy, Obstet. Gynecol., 82, 213\nMarchionni, 2004, Reproductive outcome before and after abdominal myomectomy, Fertil. Steril., 82, 154, 10.1016\u002Fj.fertnstert.2003.11.042\nVercellini, 1998, Abdominal myomectomy for infertility: a comprehensive review, Hum. Reprod., 13, 873, 10.1093\u002Fhumrep\u002F13.4.873\nBessenay, 1998, Myomectomie par voie vaginale, Contracept. Fertil. Sex., 26, 448\nDavies, 1999, Magos. The excision of uterine fibroids by vaginal myomectomy, Fertil. Steril., 71, 961, 10.1016\u002FS0015-0282(99)00061-8\nGoldberg, 2004, Pregnancy outcomes after treatment for fibromyomata: Uterine artery embolization versus laparoscopic myomectomy, Am. J. Obstet. Gynecol., 191, 18, 10.1016\u002Fj.ajog.2004.01.046",{"ES":1084},"Miomectomía mediante laparotomía",{"VOID":1086},"10.1016\u002Fs1283-081x(06)45072-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06450724",[1089,1104,1116,1131,1143],{"id":1090,"sortIndex":115,"researcher":26,"roles":1091,"affiliations":1092,"properties":1101},"c693d7de-2e71-4b89-964e-ae0f2d3c367d",[696],[1093],{"id":26,"sortIndex":36,"affiliation":1094,"properties":26},{"id":1095,"createTime":1096,"updateTime":1096,"relativeEntities":1097,"slug":26,"properties":1098,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"14f39c6f-3c3f-49e3-bb31-c2c956028cc5","2024-02-11T12:25:08.557+00:00",[],{"title":1099},{"VI":1100},"Service de chirurgie gynécologique, Hôpital Cochin, 123, boulevard de Port-Royal, 75013 Paris, France",{"title":1102},{"VI":1103},"N. Chopin",{"id":1105,"sortIndex":36,"researcher":26,"roles":1106,"affiliations":1107,"properties":1113},"008ca73a-f631-4125-b74a-59ab525f203f",[696],[1108],{"id":26,"sortIndex":36,"affiliation":1109,"properties":26},{"id":1095,"createTime":1096,"updateTime":1096,"relativeEntities":1110,"slug":26,"properties":1111,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1112},{"VI":1100},{"title":1114},{"VI":1115},"H. Foulot",{"id":1117,"sortIndex":59,"researcher":26,"roles":1118,"affiliations":1119,"properties":1128},"87ad4fe4-e79f-4d05-a878-d3df7b89bf29",[696],[1120],{"id":26,"sortIndex":36,"affiliation":1121,"properties":26},{"id":1122,"createTime":1123,"updateTime":1123,"relativeEntities":1124,"slug":26,"properties":1125,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7c483a57-8c03-41cc-b18c-49388b34a539","2024-02-11T12:25:08.545+00:00",[],{"title":1126},{"VI":1127},"Service de gynécologie obstétrique, Hôpital de Poissy, 10, rue du Champ-Gaillard, 78303 Poissy cedex, France",{"title":1129},{"VI":1130},"A. Fauconnier",{"id":1132,"sortIndex":114,"researcher":26,"roles":1133,"affiliations":1134,"properties":1140},"b52bc355-8ebf-4282-961e-7f2d1f4466f6",[696],[1135],{"id":26,"sortIndex":36,"affiliation":1136,"properties":26},{"id":1095,"createTime":1096,"updateTime":1096,"relativeEntities":1137,"slug":26,"properties":1138,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1139},{"VI":1100},{"title":1141},{"VI":1142},"C. Malartic",{"id":1144,"sortIndex":111,"researcher":26,"roles":1145,"affiliations":1146,"properties":1152},"40cb23ec-24cd-49c6-b526-382809c97b3f",[696],[1147],{"id":26,"sortIndex":36,"affiliation":1148,"properties":26},{"id":1095,"createTime":1096,"updateTime":1096,"relativeEntities":1149,"slug":26,"properties":1150,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1151},{"VI":1100},{"title":1153},{"VI":1154},"C. Chapron",{"url":1087,"publisher":1156,"properties":1164},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1157,"slug":662,"properties":1158,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1161,"manageAffiliations":1162,"indexDatabases":1163,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1159,"title":1160},{"VOID":665},{"EN":667},[],[],[],{"volume":1165,"pages":1167},{"VOID":1166},"42",{"VOID":1168},"1-6","2006-01-01",2006,{"id":1172,"createTime":1173,"updateTime":1174,"relativeEntities":1175,"slug":1176,"properties":1177,"entityType":688,"verifyStatus":25,"verifyTime":1174,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1184,"fullTextUrl":26,"authors":1185,"publicationType":747,"publisherRelationship":1356,"citationCount":26,"citationInfo":26,"publishDate":1370,"publishYear":1371,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"8307429c-6883-4948-aeaa-958672791cc1","2023-12-19T13:39:31.951+00:00","2025-02-15T22:57:56.146+00:00",[],"Lugar-de-la-cirug%C3%ADa-asistida-por-robot-en-cirug%C3%ADa-ginecol%C3%B3gica",{"references":1178,"title":1180,"doi":1182},{"VOID":1179},"Seamon, 2009, Minimally invasive comprehensive surgical staging for endometrial cancer : Robotics or laparoscopy?, Gynecol Oncol, 113, 36, 10.1016\u002Fj.ygyno.2008.12.005\nMagrina, 2008, Robotic radical hysterectomy: comparison with laparoscopy and laparotomy, Gynecol Oncol, 109, 86, 10.1016\u002Fj.ygyno.2008.01.011\nJung, 2009, Recent advances of robotic surgery and single port laparoscopy in gynecologic oncology, J Gynecol Oncol, 20, 137, 10.3802\u002Fjgo.2009.20.3.137\nRan, 2014, Comparison of robotic surgery with laparoscopy and laparotomy for treatment of endometrial cancer: a meta-analysis, PLoS One, 9, e108361, 10.1371\u002Fjournal.pone.0108361\nLim, 2016, Risk Factors and Outcomes for Conversion to Laparotomy of Laparoscopic Hysterectomy in Benign Gynecology, Obstet Gynecol, 128, 1295, 10.1097\u002FAOG.0000000000001743\nBourgin, 2017, Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer management, Eur J Surg Oncol, 43, 703, 10.1016\u002Fj.ejso.2016.10.022\nNarducci, 2020, Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial, Gynecol Oncol, 158, 382, 10.1016\u002Fj.ygyno.2020.05.010\nLavoue, 2020, Robotic surgery in gynecology: Has France lost its leadership in minimally invasive surgery?, J Gynecol Obstet Hum Reprod, 49, 101708, 10.1016\u002Fj.jogoh.2020.101708\nBelot, 2008, Cancer incidence and mortality in France over the period 1980-2005, Rev Epidemiol Sante Publique, 56, 159, 10.1016\u002Fj.respe.2008.03.117\nBhatla, 2019, Staging for carcinoma of the cervix uteri, Int J Gynaecol Obstet, 145, 129, 10.1002\u002Fijgo.12749\nCibula, 2018, The European Society of Gynaecological Oncology\u002FEuropean Society for Radiotherapy and Oncology\u002FEuropean Society of Pathology Guidelines for the Management of Patients With Cervical Cancer, Int J Gynecol Cancer, 28, 641, 10.1097\u002FIGC.0000000000001216\nRamirez, 2019, Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer. Reply, N Engl J Med, 380, 794\nMelamed, 2018, Survival after Minimally Invasive Radical Hysterectomy for EarlyStage Cervical Cancer, N Engl J Med, 379, 1905, 10.1056\u002FNEJMoa1804923\nCanlorbe, 2019, Koskas M.[Should the results of the LACC trial modify French practices for the choice of surgical approach for the treatment of early-stage cervical cancer? The point of view of the CNGOF Cancer Commission], Bull Cancer, 106, 843, 10.1016\u002Fj.bulcan.2019.05.006\nEkdahl, 2020, Increased Institutional Surgical Experience in Robot-Assisted Radical Hysterectomy for Early Stage Cervical Cancer Reduces Recurrence Rate: Results from a Nationwide Study, J Clin Med, 9, 3715, 10.3390\u002Fjcm9113715\nde Kroon, 2010, Nerve sparing in radical surgery for early-stage cervical cancer: yes we should!, Int J Gynecol Cancer, 20, S39, 10.1111\u002FIGC.0b013e3181f6381f\nNarducci, 2013, Benefit of robot-assisted laparoscopy in nerve-sparing radical hysterectomy: urinary morbidity in early cervical cancer, Surg Endosc, 27, 1237, 10.1007\u002Fs00464-012-2582-z\nGouy, 2013, Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging, J Clin Oncol, 31, 3026, 10.1200\u002FJCO.2012.47.3520\nBendifallah, 2018, Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group, Eur J Surg Oncol, 44, 1921, 10.1016\u002Fj.ejso.2018.08.013\nNarducci, 2009, Early experience of robotic-assisted laparoscopy for extraperitoneal para-aortic lymphadenectomy up to the left renal vein, Gynecol Oncol, 115, 172, 10.1016\u002Fj.ygyno.2009.04.032\nda Costa, 2018, Extraperitoneal Para-Aortic Lymphadenectomy by Robot-Assisted Laparoscopy, J Minim Invasive Gynecol, 25, 861, 10.1016\u002Fj.jmig.2017.10.040\nDiaz-Feijoo, 2014, Comparison of robotic-assisted vs conventional laparoscopy for extraperitoneal paraaortic lymphadenectomy, Gynecol Oncol, 132, 98, 10.1016\u002Fj.ygyno.2013.11.004\nBebia, 2021, Robot-assisted Extraperitoneal Para-aortic Lymphadenectomy Is Associated with Fewer Surgical Complications: A Post Hoc Analysis of the STELLA-2 Randomized Trial, J Minim Invasive Gynecol, 10.1016\u002Fj.jmig.2021.05.009\nLecuru, 2011, Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study, J Clin Oncol, 29, 1686, 10.1200\u002FJCO.2010.32.0432\nLecuru, 2019, SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study, Int J Gynecol Cancer, 29, 829, 10.1136\u002Fijgc-2019-000332\nFrumovitz, 2018, Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial, Lancet Oncol, 19, 1394, 10.1016\u002FS1470-2045(18)30448-0\nInstitut national du cancer. Les données des registres de cancers spécialisés. 2017. http:\u002F\u002Flesdonnees.e-cancer.fr\u002FThemes\u002FLes-registres-des-cancers\u002FLes-registres-de-cancers-specialises#ind33411.\nConcin, 2021, ESGO\u002FESTRO\u002FESP guidelines for the management of patients with endometrial carcinoma, Int J Gynecol Cancer, 31, 12, 10.1136\u002Fijgc-2020-002230\nQuerleu, 2017, [Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)], Gynecol Obstet Fertil Senol, 45, 715\nWalker, 2009, Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2, J Clin Oncol, 27, 5331, 10.1200\u002FJCO.2009.22.3248\nLavoue, 2014, Impact of robotics on the outcome of elderly patients with endometrial cancer, Gynecol Oncol, 133, 556, 10.1016\u002Fj.ygyno.2014.03.572\nInd, 2017, A comparison of operative outcomes between standard and robotic laparoscopic surgery for endometrial cancer: A systematic review and meta-analysis, Int J Med Robot, 13, e1851, 10.1002\u002Frcs.1851\nSeror, 2014, Laparoscopy vs robotics in surgical management of endometrial cancer: comparison of intraoperative and postoperative complications, J Minim Invasive Gynecol, 21, 120, 10.1016\u002Fj.jmig.2013.07.015\nJorgensen, 2019, Nationwide Introduction of Minimally Invasive Robotic Surgery for EarlyStage Endometrial Cancer and Its Association With Severe Complications, JAMA Surg, 154, 530, 10.1001\u002Fjamasurg.2018.5840\nPoupon, 2017, Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group, Ann Surg Oncol, 24, 1667, 10.1245\u002Fs10434-016-5735-9\nJorgensen, 2019, Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study, Eur J Cancer, 109, 1, 10.1016\u002Fj.ejca.2018.12.004\nZeng, 2015, Outcome of robotic surgery for endometrial cancer as a function of patient age, Int J Gynecol Cancer, 25, 637, 10.1097\u002FIGC.0000000000000411\nZullo, 2005, A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life, Am J Obstet Gynecol, 193, 1344, 10.1016\u002Fj.ajog.2005.02.131\nCusimano, 2019, Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications, Am J Obstet Gynecol, 221, 410e19, 10.1016\u002Fj.ajog.2019.05.004\nLavoue, 2019, J Gynecol Obstet Hum Reprod, 48, 369, 10.1016\u002Fj.jogoh.2019.03.017\nLavoue, 2019, J Gynecol Obstet Hum Reprod, 48, 379, 10.1016\u002Fj.jogoh.2019.03.018\nBolze, 2019, Gynecol Obstet Fertil Senol, 47, 168\nMerlier, 2020, Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer-A Study from the FRANCOGYN Group, J Clin Med, 9, 3528, 10.3390\u002Fjcm9113528\nGallotta, 2021, Minimally invasive surgical staging for early stage ovarian cancer: A longterm follow up, Eur J Surg Oncol, 47, 1698, 10.1016\u002Fj.ejso.2021.01.033\nFerron, 2019, Gynecol Obstet Fertil Senol, 47, 197\nBrown, 2019, When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer, J Minim Invasive Gynecol, 26, 902, 10.1016\u002Fj.jmig.2018.09.765\nKnisely, 2021, The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis, J Minim Invasive Gynecol, 28, 537, 10.1016\u002Fj.jmig.2020.11.007\nAchen, 2021, [Epithelial ovarian cancers and minimally invasive cytoreductive surgery after neoadjuvant chemotherapy: A systematic review], Gynecol Obstet Fertil Senol, 49, 736\nZhang, 2021, Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy, J Minim Invasive Gynecol, 28, 1237, 10.1016\u002Fj.jmig.2020.11.015\nCohen, 2014, Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy, JSLS, 18, 10.4293\u002FJSLS.2014.00096\nAarts, 2015, Surgical approach to hysterectomy for benign gynaecological disease, Cochrane Database Syst Rev, 2015, CD003677\nWright, 2013, Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease, JAMA, 309, 689, 10.1001\u002Fjama.2013.186\nParaiso, 2013, A randomized trial comparing conventional and robotically assisted total laparoscopic hysterectomy, Obstet Gynecol, 208, 368e1\nSarlos, 2012, Robotic compared with conventional laparoscopic hysterectomy: a randomized controlled trial, Obstet Gynecol, 120, 604, 10.1097\u002FAOG.0b013e318265b61a\nSwenson, 2016, Comparison of robotic and other minimally invasive routes of hysterectomy for benign indications, Am J Obstet Gynecol, 215, 650e1, 10.1016\u002Fj.ajog.2016.06.027\nRoh, 2018, Robot-assisted laparoscopic surgery versus conventional laparoscopic surgery in randomized controlled trials: A systematic review and meta-analysis, PLoS One, 13, e0191628, 10.1371\u002Fjournal.pone.0191628\nRosero, 2013, Comparison of robotic and laparoscopic hysterectomy for benign gynecologic disease, Obstet Gynecol, 122, 778, 10.1097\u002FAOG.0b013e3182a4ee4d\nWright, 2014, An economic analysis of robotically assisted hysterectomy, Obstet Gynecol, 123, 1038, 10.1097\u002FAOG.0000000000000244\nDeimling, 2017, Randomized controlled trial comparing operative times between standard and robot-assisted laparoscopic hysterectomy, Int J Gynaecol Obstet, 136, 64, 10.1002\u002Fijgo.12001\nAlbright, 2016, Robotic Versus Laparoscopic Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis of Randomized Trials, J Minim Invasive Gynecol, 23, 18, 10.1016\u002Fj.jmig.2015.08.003\nGest, 2019, [Robotic surgery program in gynecology: Lessons from the first 100 procedures], Gynecol Obstet Fertil Senol, 47, 825\nLuciano, 2016, The impact of robotics on the mode of benign hysterectomy and clinical outcomes, Int J Med Robot, 12, 114, 10.1002\u002Frcs.1648\nHerrinton, 2020, Outcomes of Robotic Hysterectomy for Treatment of Benign Conditions: Influence of Patient Complexity, Perm J, 24, 19035, 10.7812\u002FTPP\u002F19.035\nMoawad, 2017, Comparison of cost and operative outcomes of robotic hysterectomy compared to laparoscopic hysterectomy across different uterine weights, J Robot Surg, 11, 433, 10.1007\u002Fs11701-017-0674-4\nMoawad, 2017, Movement to outpatient hysterectomy for benign indications in the United States, 2008-2014, PLoS One, 12, e0188812, 10.1371\u002Fjournal.pone.0188812\nBarakat, 2011, Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes, Obstet Gynecol, 117, 256, 10.1097\u002FAOG.0b013e318207854f\nPundir, 2013, Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis, J Minim Invasive Gynecol, 20, 335, 10.1016\u002Fj.jmig.2012.12.010\nIlliano, 2016, Sacrocolpopexy for posthysterectomy vaginal vault prolapse: long-term follow-up, Int Urogynecol J, 27, 1563, 10.1007\u002Fs00192-016-2998-4\nLucot, 2018, Safety of Vaginal Mesh Surgery Versus Laparoscopic Mesh Sacropexy for Cystocele Repair: Results of the Prosthetic Pelvic Floor Repair Randomized Controlled Trial, Eur Urol, 74, 167, 10.1016\u002Fj.eururo.2018.01.044\nLinder, 2018, A National Contemporary Analysis of Perioperative Outcomes of Open versus Minimally Invasive Sacrocolpopexy, J Urol, 200, 862, 10.1016\u002Fj.juro.2018.03.131\nCoolen, 2017, Laparoscopic sacrocolpopexy compared with open abdominal sacrocolpopexy for vault prolapse repair: a randomised controlled trial, Int Urogynecol J, 28, 1469, 10.1007\u002Fs00192-017-3296-5\nDe Gouveia De Sa, 2016, Laparoscopic versus open sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis, Int Urogynecol J, 27, 3, 10.1007\u002Fs00192-015-2765-y\nAnand, 2017, Perioperative Complications and Cost of Vaginal, Open Abdominal, and Robotic Surgery for Apical Vaginal Vault Prolapse, Female Pelvic Med Reconstr Surg, 23, 27, 10.1097\u002FSPV.0000000000000345\nEhlert, 2016, Detailed Cost Analysis of Robotic Sacrocolpopexy Compared to Transvaginal Mesh Repair, Urology, 97, 86, 10.1016\u002Fj.urology.2016.05.072\nSerati, 2014, Robotassisted sacrocolpopexy for pelvic organ prolapse: a systematic review and meta-analysis of comparative studies, Eur Urol, 66, 303, 10.1016\u002Fj.eururo.2014.02.053\nLallemant, 2020, Evaluating the morbidity and long-term efficacy of laparoscopic sacrocolpopexy with and without robotic assistance for pelvic organ prolapse, J Robot Surg, 15, 785, 10.1007\u002Fs11701-020-01177-1\nLe Normand, 2016, [Clinical practice guidelines: Summary of recommendations for first surgical treatment of female pelvic organ prolapse by 5 French academic societies: AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP], Prog Urol, 26, S1, 10.1016\u002FS1166-7087(16)30424-9\nDubinskaya, 2020, Comparing laparoscopic and robotic sacrocolpopexy surgical outcomes with prior versus concomitant hysterectomy, Int Urogynecol J, 31, 401, 10.1007\u002Fs00192-019-04017-5\nTaylor, 2021, Endometriosis is a chronic systemic disease: clinical challenges and novel innovations, Lancet, 397, 839, 10.1016\u002FS0140-6736(21)00389-5\nSoto, 2017, Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a multicenter, randomized, controlled trial, Fertil Steril, 107, 10.1016\u002Fj.fertnstert.2016.12.033\nCollinet, 2014, Robot-assisted laparoscopy for deep infiltrating endometriosis: international multicentric retrospective study, Surg Endosc, 28, 2474, 10.1007\u002Fs00464-014-3480-3\nNezhat, 2010, Robotic versus standard laparoscopy for the treatment of endometriosis, Fertil Steril, 94, 2758, 10.1016\u002Fj.fertnstert.2010.04.031\nDarai, 2010, Randomized trial of laparoscopically assisted versus open colorectal resection for endometriosis: morbidity, symptoms, quality of life, and fertility, Ann Surg, 251, 1018, 10.1097\u002FSLA.0b013e3181d9691d\nLe Gac, 2020, Comparison of robotic versus conventional laparoscopy for the treatment of colorectal endometriosis: Pilot study of an expert center, J Gynecol Obstet Hum Reprod, 101885, 10.1016\u002Fj.jogoh.2020.101885\nJayot, 2018, Comparison of Laparoscopic Discoid Resection and Segmental Resection for Colorectal Endometriosis Using a Propensity Score Matching Analysis, J Minim Invasive Gynecol, 25, 440, 10.1016\u002Fj.jmig.2017.09.019\nNyangoh Timoh, 2015, Contribution of sacral neuromodulation to manage persistent voiding dysfunction after surgery for deep infiltrating endometriosis with colorectal involvement: preliminary results, Eur J Obstet Gynecol Reprod Biol, 190, 31, 10.1016\u002Fj.ejogrb.2015.04.011\nRaimondo, 2021, Comparison of perioperative outcomes between standard laparoscopic and robot-assisted approach in patients with rectosigmoid endometriosis, Acta Obstet Gynecol Scand, 100, 1740, 10.1111\u002Faogs.14170\nDi Maida, 2020, Robotic treatment for urinary tract endometriosis: preliminary results and surgical details in a high-volume single-Institutional cohort study, Surg Endosc, 34, 3236, 10.1007\u002Fs00464-020-07502-x\nRestaino, 2020, Robotic surgery vs laparoscopic surgery in patients with diagnosis of endometriosis: a systematic review and meta-analysis, J Robot Surg, 14, 687, 10.1007\u002Fs11701-020-01061-y\nMosbrucker, 2018, Visualization of endometriosis: comparative study of 3-dimensional robotic and 2-dimensional laparoscopic endoscopes, J Robot Surg, 12, 59, 10.1007\u002Fs11701-017-0686-0\nIanieri, 2021, Indocyanine green in the surgical management of endometriosis: A systematic review, Acta Obstet Gynecol Scand, 100, 189, 10.1111\u002Faogs.13971\nLeitao, 2014, Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers, Obstet Gynecol, 123, 1031, 10.1097\u002FAOG.0000000000000223\nDesille-Gbaguidi, 2013, Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer, Eur J Obstet Gynecol Reprod Biol, 171, 348, 10.1016\u002Fj.ejogrb.2013.09.025\nVuorinen, 2017, Costs of Robotic-Assisted Versus Traditional Laparoscopy in Endometrial Cancer, Int J Gynecol Cancer, 27, 1788, 10.1097\u002FIGC.0000000000001073\nKorsholm, 2018, A systematic review about costing methodology in robotic surgery: evidence for low quality in most of the studies, Health Econ Rev, 8, 21, 10.1186\u002Fs13561-018-0207-5\nRigaud, 2016, Technique de neurolyse du nerf pudendal par chirurgie robotique, Prog Urol, 26, 823, 10.1016\u002Fj.purol.2016.09.007\nBrännström, 2020, Live birth after robotic-assisted live donor uterus transplantation, Acta Obstet Gynecol Scand, 99, 1222, 10.1111\u002Faogs.13853\nBrannstrom, 2020, Evolution of surgical steps in robotics-assisted donor surgery for uterus transplantation: results of the eight cases in the Swedish trial, Fertil Steril, 114, 1097, 10.1016\u002Fj.fertnstert.2020.05.027\nAyoubi, 2019, Laparotomy or minimal invasive surgery in uterus transplantation: a comparison, Fertil Steril, 112, 11, 10.1016\u002Fj.fertnstert.2019.05.038\nReznick, 2006, Teaching surgical skills–changes in the wind, N Engl J Med, 355, 2664, 10.1056\u002FNEJMra054785\nParsons, 2014, Diffusion of surgical innovations, patient safety, and minimally invasive radical prostatectomy, JAMA Surg, 149, 845, 10.1001\u002Fjamasurg.2014.31\nLarcher, 2019, The Learning Curve for Robot-assisted Partial Nephrectomy: Impact of Surgical Experience on Perioperative Outcomes, Eur Urol, 75, 253, 10.1016\u002Fj.eururo.2018.08.042\nVassiliou, 2005, A global assessment tool for evaluation of intraoperative laparoscopic skills, Am J Surg, 190, 107, 10.1016\u002Fj.amjsurg.2005.04.004\nGoh, 2012, Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills, J Urol, 187, 247, 10.1016\u002Fj.juro.2011.09.032\nHung, 2018, Development and Validation of Objective Performance Metrics for Robot-Assisted Radical Prostatectomy: A Pilot Study, J Urol, 199, 296, 10.1016\u002Fj.juro.2017.07.081\nVanlander, 2020, Orsi Consensus Meeting on European Robotic Training (OCERT): Results from the First Multispecialty Consensus Meeting on Training in Robot-assisted Surgery, Eur Urol, 78, 713, 10.1016\u002Fj.eururo.2020.02.003\nScott, 2020, Design and validation of a cross-specialty simulation-based training course in basic robotic surgical skills, Int J Med Robot, 16, 1, 10.1002\u002Frcs.2138\nHung, 2013, Comparative assessment of three standardized robotic surgery training methods, BJU Int, 112, 864, 10.1111\u002Fbju.12045",{"ES":1181},"Lugar de la cirugía asistida por robot en cirugía ginecológica",{"VOID":1183},"10.1016\u002Fs1283-081x(23)47726-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X23477260",[1186,1201,1228,1247,1266,1292,1318,1337],{"id":1187,"sortIndex":59,"researcher":26,"roles":1188,"affiliations":1189,"properties":1198},"31af1e4f-3098-4ad3-bc1b-a6811f366a4e",[696],[1190],{"id":26,"sortIndex":36,"affiliation":1191,"properties":26},{"id":1192,"createTime":1193,"updateTime":1193,"relativeEntities":1194,"slug":26,"properties":1195,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a02c5a65-be60-43e3-b9f7-e24691fff83a","2023-12-19T13:39:31.993+00:00",[],{"title":1196},{"VI":1197},"Équipe MEDICIS, Laboratoire du traitement du signal et de l’image, Inserm UMR 1099, 35000 Rennes, France",{"title":1199},{"VI":1200},"P. Jannin",{"id":1202,"sortIndex":135,"researcher":26,"roles":1203,"affiliations":1204,"properties":1225},"2dce3d01-fb5a-47b5-8ebe-9aa19e84bc89",[696],[1205,1213],{"id":26,"sortIndex":36,"affiliation":1206,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1209,"slug":26,"properties":1210,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e9adeaa0-48b7-4af4-b257-c9a854e307f0","2023-12-19T13:39:32.136+00:00",[],{"title":1211},{"VI":1212},"Service de gynécologie, Département de gynécologie, obstétrique et reproduction humaine, Pôle Femme–Enfant, CHU de Rennes, Hôpital Sud, 16, boulevard de Bulgarie, 35000 Rennes, France",{"id":1214,"sortIndex":115,"affiliation":1215,"properties":1224},"45ad911b-21dd-47be-a199-a12befb236e4",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1219,"slug":1220,"properties":1221,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"01c49636-812c-4367-9260-125880a06c17","2023-12-19T13:39:32.130+00:00","2025-06-11T15:12:39.947+00:00",[],"Facult%C3%A9-de-m%C3%A9decine-Universit%C3%A9-de-Rennes-1-rue-Henri-Guillou-35000-Rennes-France",{"title":1222},{"VI":1223},"Faculté de médecine, Université de Rennes-1, rue Henri-Guillou, 35000 Rennes, France",{},{"title":1226},{"VI":1227},"J. Levêque",{"id":1229,"sortIndex":162,"researcher":26,"roles":1230,"affiliations":1231,"properties":1244},"f2d0bd08-8367-4c23-8b1b-6e03a326305e",[696],[1232,1237],{"id":26,"sortIndex":36,"affiliation":1233,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1234,"slug":26,"properties":1235,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1236},{"VI":1212},{"id":1238,"sortIndex":115,"affiliation":1239,"properties":1243},"33308b2d-b095-429a-80a5-5df5a93f2276",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1240,"slug":1220,"properties":1241,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1242},{"VI":1223},{},{"title":1245},{"VI":1246},"M. Mairé",{"id":1248,"sortIndex":158,"researcher":26,"roles":1249,"affiliations":1250,"properties":1263},"5e55620f-81e6-4868-b04d-5268eece6215",[696],[1251,1258],{"id":1252,"sortIndex":115,"affiliation":1253,"properties":1257},"61aaf296-95bd-4f43-aaa2-6051d5341424",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1254,"slug":1220,"properties":1255,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1256},{"VI":1223},{},{"id":26,"sortIndex":36,"affiliation":1259,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1260,"slug":26,"properties":1261,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1262},{"VI":1212},{"title":1264},{"VI":1265},"V. Lavoué",{"id":1267,"sortIndex":115,"researcher":26,"roles":1268,"affiliations":1269,"properties":1289},"18f6cc2a-91d3-4605-ad5e-038d72ad690c",[696],[1270,1275,1282],{"id":26,"sortIndex":36,"affiliation":1271,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1272,"slug":26,"properties":1273,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1274},{"VI":1212},{"id":1276,"sortIndex":115,"affiliation":1277,"properties":1281},"3206a23a-a8cf-41fb-b876-bfdf0b1b66c3",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1278,"slug":1220,"properties":1279,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1280},{"VI":1223},{},{"id":1283,"sortIndex":114,"affiliation":1284,"properties":1288},"4a4d8e68-1673-4a07-92c7-895a64786813",{"id":1192,"createTime":1193,"updateTime":1193,"relativeEntities":1285,"slug":26,"properties":1286,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1287},{"VI":1197},{},{"title":1290},{"VI":1291},"K. Nyangoh Timoh",{"id":1293,"sortIndex":114,"researcher":26,"roles":1294,"affiliations":1295,"properties":1315},"89335435-812e-4fcc-bb87-378ebdfcc4cf",[696],[1296,1303,1308],{"id":1297,"sortIndex":114,"affiliation":1298,"properties":1302},"9858a86d-be42-4255-b201-3e84ff7b448a",{"id":1192,"createTime":1193,"updateTime":1193,"relativeEntities":1299,"slug":26,"properties":1300,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1301},{"VI":1197},{},{"id":26,"sortIndex":36,"affiliation":1304,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1305,"slug":26,"properties":1306,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1307},{"VI":1212},{"id":1309,"sortIndex":115,"affiliation":1310,"properties":1314},"a9ddaf27-a5e0-48a7-8fc2-73e098bacc8a",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1311,"slug":1220,"properties":1312,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1313},{"VI":1223},{},{"title":1316},{"VI":1317},"S. Guérin",{"id":1319,"sortIndex":36,"researcher":26,"roles":1320,"affiliations":1321,"properties":1334},"ca7a5625-3e26-4228-a9a0-f4811bd824d6",[696],[1322,1327],{"id":26,"sortIndex":36,"affiliation":1323,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1324,"slug":26,"properties":1325,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1326},{"VI":1212},{"id":1328,"sortIndex":115,"affiliation":1329,"properties":1333},"0d0fc3d1-02ae-4be2-b28c-49b14df65ac5",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1330,"slug":1220,"properties":1331,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1332},{"VI":1223},{},{"title":1335},{"VI":1336},"L. Dion",{"id":1338,"sortIndex":111,"researcher":26,"roles":1339,"affiliations":1340,"properties":1353},"ec6d2cfe-a57b-4992-b569-05c18d8133b9",[696],[1341,1346],{"id":26,"sortIndex":36,"affiliation":1342,"properties":26},{"id":1207,"createTime":1208,"updateTime":1208,"relativeEntities":1343,"slug":26,"properties":1344,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1345},{"VI":1212},{"id":1347,"sortIndex":115,"affiliation":1348,"properties":1352},"7c48df32-5aea-4bb6-98cd-fee9b285fd6c",{"id":1216,"createTime":1217,"updateTime":1218,"relativeEntities":1349,"slug":1220,"properties":1350,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1351},{"VI":1223},{},{"title":1354},{"VI":1355},"M. Joste",{"url":1184,"publisher":1357,"properties":1365},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1358,"slug":662,"properties":1359,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1362,"manageAffiliations":1363,"indexDatabases":1364,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1360,"title":1361},{"VOID":665},{"EN":667},[],[],[],{"volume":1366,"pages":1368},{"VOID":1367},"59",{"VOID":1369},"1-11","2023-06-01",2023,{"id":1373,"createTime":1374,"updateTime":1375,"relativeEntities":1376,"slug":1377,"properties":1378,"entityType":688,"verifyStatus":25,"verifyTime":1375,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1385,"fullTextUrl":26,"authors":1386,"publicationType":747,"publisherRelationship":1472,"citationCount":26,"citationInfo":26,"publishDate":1485,"publishYear":1486,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ca12db1a-3443-43fb-aeae-5ad6cc433954","2023-11-25T20:26:47.332+00:00","2025-02-16T00:29:10.368+00:00",[],"Fisiolog%C3%ADa-y-patolog%C3%ADas-del-cord%C3%B3n-umbilical",{"references":1379,"title":1381,"doi":1383},{"VOID":1380},"Weissman, 1994, Sonographic measurements of the umbilical cord and vessels during normal pregnancies, J Ultrasound Med, 13, 11, 10.7863\u002Fjum.1994.13.1.11\nTakechi, 1993, Ultrastructural and immunohistochemical studies of Wharton's jelly umbilical cord cells, Placenta, 14, 235, 10.1016\u002FS0143-4004(05)80264-4\nLarsen, 2003\nSéminaire de chirurgie pédiatrique viscérale, 2010, Malformations congénitales de la paroi abdominale et diagnostic anténatal\nHegazy, 2016, Anatomy and embryology of umbilicus in newborns: a review and clinical correlations, Front Med, 10, 271, 10.1007\u002Fs11684-016-0457-8\nRazvi, 2001, Delayed separation of the umbilical cord attributable to urachal anomalies, Pediatrics, 108, 493, 10.1542\u002Fpeds.108.2.493\nSpeert, 1956, Obstetric-gynecologic eponyms; Thomas Wharton and the jelly of the umbilical cord, Obstet Gynecol, 8, 380\nKierszenbaum, 2006\nKarahuseyinoglu, 2007, Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys, Stem Cells, 25, 319, 10.1634\u002Fstemcells.2006-0286\nCoujard, 1980\nKim, 2013, Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications, Int J Mol Sci, 14, 11692, 10.3390\u002Fijms140611692\nGhezzi, 2001, Nomogram of Wharton's jelly as depicted in the sonographic cross section of the umbilical cord, Ultrasound Obstet Gynecol, 18, 121, 10.1046\u002Fj.1469-0705.2001.00468.x\nGoodlin, 1987, Fetal dysmaturity, lean cord, and fetal distress, Am J Obstet Gynecol, 156, 1357, 10.1016\u002F0002-9378(87)90180-3\nDi Naro, 2001, Umbilical vein blood flow in fetuses with normal and lean umbilical cord, Ultrasound Obstet Gynecol, 17, 224, 10.1046\u002Fj.1469-0705.2001.00309.x\nWeissman, 1997, Sonographic measurements of the umbilical cord in pregnancies complicated by gestational diabetes, J Ultrasound Med, 16, 691, 10.7863\u002Fjum.1997.16.10.691\nWang, 2004, Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord, Stem Cells, 22, 1330, 10.1634\u002Fstemcells.2004-0013\nLi, 2013, Differentiation of mesenchymal stem cells from human umbilical cord tissue into odontoblast-like cells using the conditioned medium of tooth germ cells in vitro, Biomed Res Int, 2013, 218543\nBoyd, 1970\nPathak, 2010, Cord coiling, umbilical cord insertion and placental shape in an unselected cohort delivering at term: relationship with common obstetric outcomes, Placenta, 31, 963, 10.1016\u002Fj.placenta.2010.08.004\nBrody, 1953, Marginal insertion of the cord and premature labor, Am J Obstet Gynecol, 65, 1305, 10.1016\u002F0002-9378(53)90371-8\nHathout, 1964, The vascular pattern and mode of insertion of the umbilical cord in abortion material, J Obstet Gynaecol Br Commonw, 71, 963, 10.1111\u002Fj.1471-0528.1964.tb04388.x\nMonie, 1965, Velamentous insertion of the cord in early pregnancy, Am J Obstet Gynecol, 93, 276, 10.1016\u002F0002-9378(65)90670-8\nProctor, 2013, Umbilical cord diameter percentile curves and their correlation to birth weight and placental pathology, Placenta, 34, 62, 10.1016\u002Fj.placenta.2012.10.015\nCromi, 2007, Large cross-sectional area of the umbilical cord as a predictor of fetal macrosomia, Ultrasound Obstet Gynecol, 30, 861, 10.1002\u002Fuog.5183\nRazavi, 2008\nGilbert, 1974, Torsion and constriction of the umbilical cord. A cause of fetal death, Arch Pathol, 97, 58\nShenker, 1981, Ultrasound demonstration of masses in a 15 week fetus: hydrops in a fetus with umbilical cord occlusion, Prenat Diagn, 1, 217, 10.1002\u002Fpd.1970010307\nTavares Fortuna, 1978, Coarctation of the umbilical cord: a cause of intrauterine fetal death, Int J Gynaecol Obstet, 15, 469, 10.1002\u002Fj.1879-3479.1977.tb00735.x\nLing, 2006, Umbilical cord stricture causing intrauterine fetal death in a 22-week fetus, Taiwan J Obstet Gynecol, 45, 73, 10.1016\u002FS1028-4559(09)60197-2\nGeorgiadis, 2014, Umbilical cord length in singleton gestations: a Finnish population-based retrospective register study, Placenta, 35, 275, 10.1016\u002Fj.placenta.2014.02.001\nGhezzi, 2001, First-trimester sonographic umbilical cord diameter and the growth of the human embryo, Ultrasound Obstet Gynecol, 18, 348, 10.1046\u002Fj.0960-7692.2001.00507.x\nBarbieri, 2012, Sonographic measurement of the umbilical cord area and the diameters of its vessels during pregnancy, J Obstet Gynaecol, 32, 230, 10.3109\u002F01443615.2011.647129\nMoinian, 1969, Diameters of umbilical cord vessels and the weight of the cord in relation to clamping time, Am J Obstet Gynecol, 105, 604\nVimpeli, 2009, Fetal cardiac output and its distribution to the placenta at 11-20 weeks of gestation, Ultrasound Obstet Gynecol, 33, 265, 10.1002\u002Fuog.6247\nAcharya, 2005, Reference ranges for umbilical vein blood flow in the second half of pregnancy based on longitudinal data, Prenat Diagn, 25, 99, 10.1002\u002Fpd.1091\nRaio, 2001, In-utero characterization of the blood flow in the Hyrtl anastomosis, Placenta, 22, 597, 10.1053\u002Fplac.2001.0685\nMarzioni, 2004, Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A, Dev Dyn, 231, 839, 10.1002\u002Fdvdy.20178\nAdinma, 1993, The umbilical cord: a study of 1000 consecutive deliveries, Int J Fertil Menopausal Stud, 38, 175\nStefos, 2003, Umbilical cord length and parity--the Greek experience, Eur J Obstet Gynecol Reprod Biol, 107, 41, 10.1016\u002FS0301-2115(02)00307-X\nHeifetz, 1996, The umbilical cord: obstetrically important lesions, Clin Obstet Gynecol, 39, 571, 10.1097\u002F00003081-199609000-00007\nVerkleij, 2013, Evaluation of antenatal umbilical coiling index at 16-21 weeks of gestation as a predictor of trisomy 21 and other chromosomal defects, Ultrasound Obstet Gynecol, 42, 545, 10.1002\u002Fuog.12443\nAcharya, 2016, Hemodynamic aspects of normal human feto-placental (umbilical) circulation, Acta Obstet Gynecol Scand, 95, 672, 10.1111\u002Faogs.12919\nJouannic, 2004, An update on the fetal circulation, J Gynecol Obstet Biol Reprod (Paris), 33, 291, 10.1016\u002FS0368-2315(04)96457-5\nArduini, 1991, Umbilical artery velocity waveforms in early pregnancy: a transvaginal color Doppler study, J Clin Ultrasound, 19, 335, 10.1002\u002Fjcu.1870190603\nLudomirsky, 1994\nHasegawa, 2010, Detection of umbilical venous constriction by Doppler flow measurement at midgestation, Ultrasound Obstet Gynecol, 36, 196, 10.1002\u002Fuog.7695\nNicolaides, 1989, Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses, Am J Obstet Gynecol, 161, 996, 10.1016\u002F0002-9378(89)90770-9\nLazarević, 1991, Respiratory gases and acid base parameter of the fetus during the second and third trimester, Clin Exp Obstet Gynecol, 18, 81\nKiserud, 2000, Blood flow and the degree of shunting through the ductus venosus in the human fetus, Am J Obstet Gynecol, 182, 147, 10.1016\u002FS0002-9378(00)70504-7\nVille, 1994, Umbilical venous pressure in normal, growth-retarded, and anemic fetuses, Am J Obstet Gynecol, 170, 487, 10.1016\u002FS0002-9378(94)70216-0\nNyberg, 2010, Fetal breathing is associated with increased umbilical blood flow, Ultrasound Obstet Gynecol, 36, 718, 10.1002\u002Fuog.7701\nDegani, 1995, Sonographic estimation of umbilical coiling index and correlation with Doppler flow characteristics, Obstet Gynecol, 86, 990, 10.1016\u002F0029-7844(95)00307-D\nEl Behery, 2011, Effect of umbilical vein blood flow on perinatal outcome of fetuses with lean and\u002For hypo-coiled umbilical cord, Arch Gynecol Obstet, 283, 53, 10.1007\u002Fs00404-009-1272-0\nGoldkrand, 2001, Volumetric umbilical artery blood flow: comparison of the normal versus the single umbilical artery cord, J Matern Fetal Med, 10, 116, 10.1080\u002Fjmf.10.2.116.121\nBaron, 2015, Umbilical artery blood flows among pregnancies with single umbilical artery: a prospective case-control study, J Matern Fetal Neonatal Med, 28, 1803, 10.3109\u002F14767058.2014.968845\nFujiyama, 1971, Nerve distribution in human fetal appendages, particularly in the umbilical cord, Tohoku J Exp Med, 105, 111, 10.1620\u002Ftjem.105.111\nBjøro, 1986, Effects of vasoactive autacoids on different segments of human umbilicoplacental vessels, Gynecol Obstet Invest, 22, 1, 10.1159\u002F000298881\nSkulstad, 2005, The effect of umbilical venous constriction on placental development, cord length and perinatal outcome, Early Hum Dev, 81, 325, 10.1016\u002Fj.earlhumdev.2004.07.006\nLovren, 2000, Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery, Br J Pharmacol, 131, 521, 10.1038\u002Fsj.bjp.0703588\nMauro, 2011, Human umbilical cord expresses several vasoactive peptides involved in the local regulation of vascular tone: protein and gene expression of orphanin, oxytocin, ANP, eNOS and iNOS, Folia Histochem Cytobiol, 49, 211, 10.5603\u002FFHC.2011.0029\nFarina-Lipari, 2003, Presence of atrial natriuretic factor in normal and hyperplastic human prostate and its relationship with oxytocin localisation, Eur J Histochem, 47, 133, 10.4081\u002F818\nTempleton, 1994, Atrial natriuretic peptide counteracts the vasoconstrictor effects of 5-hydroxytryptamine, U46619 and endothelin-1 in the human umbilical artery, Placenta, 15, 715, 10.1016\u002F0143-4004(94)90034-5\nFurchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038\u002F288373a0\nChen, 2015, Muscarinic-mediated vasoconstriction in human, rat and sheep umbilical cords and related vasoconstriction mechanisms, BJOG, 122, 1630, 10.1111\u002F1471-0528.13144\nGude, 1990, Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta, Lancet, 336, 1589, 10.1016\u002F0140-6736(90)93374-X\nZadeh, 2000, Regulation of ICAM-1\u002FCD54 expression on human endothelial cells by hydrogen peroxide involves inducible NO synthase, J Leukoc Biol, 67, 327, 10.1002\u002Fjlb.67.3.327\nCorbett, 1999, Nitric oxide in fracture repair. Differential localisation, expression and activity of nitric oxide synthases, J Bone Joint Surg Br, 81, 531, 10.1302\u002F0301-620X.81B3.8852\nBredt, 1999, Endogenous nitric oxide synthesis: biological functions and pathophysiology, Free Radic Res, 31, 577, 10.1080\u002F10715769900301161\nWu, 1996, Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats, Biochem Biophys Res Commun, 228, 459, 10.1006\u002Fbbrc.1996.1682\nRefuerzo, 2006, Sildenafil citrate and fetal outcome in pregnant rats, Fetal Diagn Ther, 21, 259, 10.1159\u002F000091352\nSatterfield, 2010, Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction, J Nutr, 140, 251, 10.3945\u002Fjn.109.114678\nvon Dadelszen, 2011, Sildenafil citrate therapy for severe early-onset intrauterine growth restriction, BJOG, 118, 624, 10.1111\u002Fj.1471-0528.2010.02879.x\nWareing, 2006, Reactivity of human placental chorionic plate vessels from pregnancies complicated by intrauterine growth restriction (IUGR), Biol Reprod, 75, 518, 10.1095\u002Fbiolreprod.106.051607\nDastjerdi, 2012, Sildenafil citrate and uteroplacental perfusion in fetal growth restriction, J Res Med Sci, 17, 632\nRomero, 1992, The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology, Am J Obstet Gynecol, 166, 1382, 10.1016\u002F0002-9378(92)91609-E\nDuchatel, 1993, Complications of diagnostic ultrasound-guided percutaneous umbilical blood sampling: analysis of a series of 341 cases and review of the literature, Eur J Obstet Gynecol Reprod Biol, 52, 95, 10.1016\u002F0028-2243(93)90234-4\nJauniaux, 1989, Pathologic aspects of the umbilical cord after percutaneous umbilical blood sampling, Obstet Gynecol, 73, 215\nHill, 2010, Umbilical artery aneurysm, Obstet Gynecol, 116, 559, 10.1097\u002FAOG.0b013e3181e7d280\nBendon, 1991, Umbilical cord ulceration and intestinal atresia: a new association?, Am J Obstet Gynecol, 164, 582, 10.1016\u002FS0002-9378(11)80026-8\nHill, 1994, Sonographic determination of first trimester umbilical cord length, J Clin Ultrasound, 22, 435, 10.1002\u002Fjcu.1870220704\nVan Allen, 1987, Limb body wall complex: I. Pathogenesis, Am J Med Genet, 28, 529, 10.1002\u002Fajmg.1320280302\nVan Allen, 1987, Limb-body wall complex: II. Limb and spine defects, Am J Med Genet, 28, 549, 10.1002\u002Fajmg.1320280303\nDeruelle, 2000, Antenatal diagnosis of limb body wall complex, J Gynecol Obstet Biol Reprod (Paris), 29, 385\nBhat, 2016, Prenatal sonographic diagnosis of limb-body wall complex: case series of a rare congenital anomaly, Radiol Case Rep, 11, 116, 10.1016\u002Fj.radcr.2016.02.004\nMoerman, 1992, Constrictive amniotic bands, amniotic adhesions, and limb-body wall complex: discrete disruption sequences with pathogenetic overlap, Am J Med Genet, 42, 470, 10.1002\u002Fajmg.1320420412\nSeeds, 1982, Amniotic band syndrome, Am J Obstet Gynecol, 144, 243, 10.1016\u002F0002-9378(82)90574-9\nHartwig, 1989, Limb body wall malformation complex: an embryologic etiology?, Hum Pathol, 20, 1071, 10.1016\u002F0046-8177(89)90225-6\nGilbert-Barness, 2001, Evidence for the « midline » hypothesis in associated defects of laterality formation and multiple midline anomalies, Am J Med Genet, 101, 382, 10.1002\u002Fajmg.1224\nGajzer, 2015, Possible genetic origin of limb-body wall complex, Fetal Pediatr Pathol, 34, 257, 10.3109\u002F15513815.2015.1055021\nKruszka, 2015, Limb body wall complex, amniotic band sequence, or new syndrome caused by mutation in IQ Motif containing K (IQCK)?, Mol Genet Genomic Med, 3, 424, 10.1002\u002Fmgg3.153\nPeregrine, 2005, Ultrasound detection of nuchal cord prior to labor induction and the risk of Cesarean section, Ultrasound Obstet Gynecol, 25, 160, 10.1002\u002Fuog.1767\nKan-Pun-Shui, 1957, Coiling of the umbilical cord around the foetal neck, J Obstet Gynaecol Br Emp, 64, 227, 10.1111\u002Fj.1471-0528.1957.tb02625.x\nHershkovitz, 2001, Risk factors associated with true knots of the umbilical cord, Eur J Obstet Gynecol Reprod Biol, 98, 36, 10.1016\u002FS0301-2115(01)00312-8\nAbuhamad, 2014, Three-dimensional ultrasound with color Doppler imaging of an umbilical cord true knot, Ultrasound Obstet Gynecol, 43, 360, 10.1002\u002Fuog.13297\nGranese, 2007, The value of single umbilical artery in the prediction of fetal aneuploidy: findings in 12,672 pregnant women, Ultrasound Q, 23, 117, 10.1097\u002F01.ruq.0000263848.07808.02\nThummala, 1998, Isolated single umbilical artery anomaly and the risk for congenital malformations: a meta-analysis, J Pediatr Surg, 33, 580, 10.1016\u002FS0022-3468(98)90320-7\nRembouskos, 2003, Single umbilical artery at 11-14 weeks’ gestation: relation to chromosomal defects, Ultrasound Obstet Gynecol, 22, 567, 10.1002\u002Fuog.901\nChow, 1998, Frequency and nature of structural anomalies in fetuses with single umbilical arteries, J Ultrasound Med, 17, 765, 10.7863\u002Fjum.1998.17.12.765\nVoskamp, 2013, Relationship of isolated single umbilical artery to fetal growth, aneuploidy and perinatal mortality: systematic review and meta-analysis, Ultrasound Obstet Gynecol, 42, 622, 10.1002\u002Fuog.12541\nAbuhamad, 1995, Single umbilical artery: does it matter which artery is missing?, Am J Obstet Gynecol, 173, 728, 10.1016\u002F0002-9378(95)90331-3\nPredanic, 2005, Fetal growth assessment and neonatal birth weight in fetuses with an isolated single umbilical artery, Obstet Gynecol, 105, 1093, 10.1097\u002F01.AOG.0000158108.51397.f5\nGutvirtz, 2016, Isolated single umbilical artery is an independent risk factor for perinatal mortality and adverse outcomes in term neonates, Arch Gynecol Obstet, 10.1007\u002Fs00404-016-4088-8\nLacro, 1987, The umbilical cord twist: origin, direction, and relevance, Am J Obstet Gynecol, 157, 833, 10.1016\u002FS0002-9378(87)80067-4\nRaio, 1999, Prenatal assessment of Wharton's jelly in umbilical cords with single artery, Ultrasound Obstet Gynecol, 14, 42, 10.1046\u002Fj.1469-0705.1999.14010042.x\nGornall, 2003, Antenatal detection of a single umbilical artery: does it matter?, Prenat Diagn, 23, 117, 10.1002\u002Fpd.540\nMartínez-Payo, 2014, Detection of single umbilical artery in the first trimester ultrasound: its value as a marker of fetal malformation, Bio Med Res Int, 2014, 548729\nLubusky, 2007, Single umbilical artery and its siding in the second trimester of pregnancy: relation to chromosomal defects, Prenat Diagn, 27, 327, 10.1002\u002Fpd.1672\nChavali, 2014, Immature teratoma at umbilicus region presenting as exomphalos: a case report with review of literature, Indian J Med Paediatr Oncol, 35, 231, 10.4103\u002F0971-5851.142042\nSepulveda, 1999, Pseudocyst of the umbilical cord: prenatal sonographic appearance and clinical significance, Obstet Gynecol, 93, 377\nKiran, 2003, Pseudocyst of the umbilical cord with mucoid degeneration of Wharton's jelly, Eur J Obstet Gynecol Reprod Biol, 111, 91, 10.1016\u002FS0301-2115(03)00120-9\nSepulveda, 2003, Beware of the umbilical cord “cyst”, Ultrasound Obstet Gynecol, 21, 213, 10.1002\u002Fuog.80\nSherer, 1997, Prenatal ultrasonographic morphologic assessment of the umbilical cord: a review. Part I, Obstet Gynecol Surv, 52, 506, 10.1097\u002F00006254-199708000-00022\nRasteiro, 2013, Bladder emptying into an umbilical cord cyst: prenatal sonographic sign of allantoic cyst with patent urachus, Ultrasound Obstet Gynecol, 42, 239, 10.1002\u002Fuog.12361\nShukunami, 2000, Prenatal sonographic features of vesicoallantoic cyst, Ultrasound Obstet Gynecol, 15, 545, 10.1046\u002Fj.1469-0705.2000.00129.x\nNobuhara, 2004, The giant umbilical cord: an unusual presentation of a patent urachus, J Pediatr Surg, 39, 128, 10.1016\u002Fj.jpedsurg.2003.09.023\nBunch, 2006, Allantoic cyst: a prenatal clue to patent urachus, Pediatr Radiol, 36, 1090, 10.1007\u002Fs00247-006-0260-9\nRosenberg, 1986, Antenatal sonographic appearance of omphalomesenteric duct cyst, J Ultrasound Med, 5, 719, 10.7863\u002Fjum.1986.5.12.719\nWeber, 2007, Third trimester intrauterine fetal death caused by arterial aneurysm of the umbilical cord, Pediatr Dev Pathol, 10, 305, 10.2350\u002F06-07-0136.1\nVyas, 2016, Prenatal diagnosis of umbilical artery aneurysm with good fetal outcome and review of literature, J Clin Diagn Res, 10\nSepulveda, 2003, Umbilical artery aneurysm: prenatal identification in three fetuses with trisomy 18, Ultrasound Obstet Gynecol, 21, 292, 10.1002\u002Fuog.69\nDeront-Bourdin, 2014, Umbilical vein varix thrombosis, Gynecol Obstet Fertil, 42, 448, 10.1016\u002Fj.gyobfe.2014.01.018\nByers, 2009, Pregnancy outcome after ultrasound diagnosis of fetal intra-abdominal umbilical vein varix, Ultrasound Obstet Gynecol, 33, 282, 10.1002\u002Fuog.6233\nSmulian, 2016, The natural history of an umbilical cord hemangioma, J Clin Ultrasound, 44, 455, 10.1002\u002Fjcu.22346\nMatsuda, 2011, Hemangioma of the umbilical cord with pseudocyst, Fetal Pediatr Pathol, 30, 16, 10.3109\u002F15513811003796920\nGonzález-Gleason, 2012, Rupture of umbilical cord chorioangioma, intraamniotic hemorrhage and fetal death: report of a case and review of the literature, Ginecol Obstet Mexico, 80, 104\nHeifetz, 1988, Thrombosis of the umbilical cord: analysis of 52 cases and literature review, Pediatr Pathol, 8, 37, 10.3109\u002F15513818809022278\nSato, 2006, Umbilical arterial thrombosis with vascular wall necrosis: clinicopathologic findings of 11 cases, Placenta, 27, 715, 10.1016\u002Fj.placenta.2005.05.008\nKanenishi, 2013, HDlive imaging of intra-amniotic umbilical vein varix with thrombosis, Placenta, 34, 1110, 10.1016\u002Fj.placenta.2013.08.008\nStiller, 2003, Prenatal diagnosis of portal vein thrombosis by ultrasound, Ultrasound Obstet Gynecol, 22, 295, 10.1002\u002Fuog.216",{"ES":1382},"Fisiología y patologías del cordón umbilical",{"VOID":1384},"10.1016\u002Fs1283-081x(17)86887-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17868879",[1387,1414,1430,1449],{"id":1388,"sortIndex":59,"researcher":26,"roles":1389,"affiliations":1390,"properties":1411},"bc8fa10d-4179-4521-9ec6-f9a301d896c2",[696],[1391,1402],{"id":1392,"sortIndex":115,"affiliation":1393,"properties":1401},"542e3f32-0d0b-4b11-87cd-47f3d1cc3af1",{"id":1394,"createTime":1395,"updateTime":1395,"relativeEntities":1396,"slug":1397,"properties":1398,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"115deb32-38f5-41c5-acff-79eb7fc4f8f2","2023-11-25T20:26:47.347+00:00",[],"Universit%C3%A9-de-Bourgogne-Franche-Comt%C3%A9-France",{"title":1399},{"VI":1400},"Université de Bourgogne-Franche-Comté, France",{},{"id":26,"sortIndex":36,"affiliation":1403,"properties":26},{"id":1404,"createTime":1405,"updateTime":1405,"relativeEntities":1406,"slug":1407,"properties":1408,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"900694d2-8584-4f61-894e-34f43c661a95","2023-11-25T20:26:47.366+00:00",[],"Service-gyn%C3%A9cologie-obst%C3%A9trique-P%C3%B4le-m%C3%A8re-femme-H%C3%B4pital-Jean-Minjoz-CHU-3-boulevard-Flemming-25030-Besan%C3%A7on-cedex-France",{"title":1409},{"VI":1410},"Service gynécologie-obstétrique, Pôle mère-femme, Hôpital Jean-Minjoz, CHU, 3, boulevard Flemming, 25030 Besançon cedex, France",{"title":1412},{"VI":1413},"D. Riethmuller",{"id":1415,"sortIndex":114,"researcher":26,"roles":1416,"affiliations":1417,"properties":1427},"4efc6dca-095f-4359-9fdc-ab56ec217441",[696],[1418],{"id":26,"sortIndex":36,"affiliation":1419,"properties":26},{"id":1420,"createTime":1421,"updateTime":1421,"relativeEntities":1422,"slug":1423,"properties":1424,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"18da9405-f337-4bf7-8621-038a7ef932c3","2023-11-25T20:26:47.361+00:00",[],"Service-d-anatomopathologie-H%C3%B4pital-Jean-Minjoz-CHU-3-boulevard-Flemming-25030-Besan%C3%A7on-cedex-France",{"title":1425},{"VI":1426},"Service d’anatomopathologie, Hôpital Jean-Minjoz, CHU, 3, boulevard Flemming, 25030 Besançon cedex, France",{"title":1428},{"VI":1429},"F. Arbez-Gindre",{"id":1431,"sortIndex":36,"researcher":26,"roles":1432,"affiliations":1433,"properties":1446},"647b130c-6dc1-4082-916f-9605a30679af",[696],[1434,1439],{"id":26,"sortIndex":36,"affiliation":1435,"properties":26},{"id":1404,"createTime":1405,"updateTime":1405,"relativeEntities":1436,"slug":1407,"properties":1437,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1438},{"VI":1410},{"id":1440,"sortIndex":115,"affiliation":1441,"properties":1445},"b9e9d71d-7e46-4fd1-9421-202c87fc377d",{"id":1394,"createTime":1395,"updateTime":1395,"relativeEntities":1442,"slug":1397,"properties":1443,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1444},{"VI":1400},{},{"title":1447},{"VI":1448},"N. Mottet",{"id":1450,"sortIndex":115,"researcher":26,"roles":1451,"affiliations":1452,"properties":1469},"6aed2696-e10e-4af9-b304-3a90d09cdaac",[696],[1453,1458],{"id":26,"sortIndex":36,"affiliation":1454,"properties":26},{"id":1394,"createTime":1395,"updateTime":1395,"relativeEntities":1455,"slug":1397,"properties":1456,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1457},{"VI":1400},{"id":1459,"sortIndex":115,"affiliation":1460,"properties":1468},"1349b1f3-950e-4f2a-89a4-f4510a979389",{"id":1461,"createTime":1462,"updateTime":1462,"relativeEntities":1463,"slug":1464,"properties":1465,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"dba97e5c-3d80-4602-9891-f8adef51b6be","2023-11-25T20:26:47.355+00:00",[],"Service-de-chirurgie-p%C3%A9diatrique-H%C3%B4pital-Jean-Minjoz-CHU-3-boulevard-Flemming-25030-Besan%C3%A7on-cedex-France",{"title":1466},{"VI":1467},"Service de chirurgie pédiatrique, Hôpital Jean-Minjoz, CHU, 3, boulevard Flemming, 25030 Besançon cedex, France",{},{"title":1470},{"VI":1471},"Y. Chaussy",{"url":1385,"publisher":1473,"properties":1481},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1474,"slug":662,"properties":1475,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1478,"manageAffiliations":1479,"indexDatabases":1480,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1476,"title":1477},{"VOID":665},{"EN":667},[],[],[],{"volume":1482,"pages":1484},{"VOID":1483},"53",{"VOID":761},"2017-12-01",2017,{"id":1488,"createTime":1489,"updateTime":1490,"relativeEntities":1491,"slug":1492,"properties":1493,"entityType":688,"verifyStatus":25,"verifyTime":1490,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1500,"fullTextUrl":26,"authors":1501,"publicationType":747,"publisherRelationship":1544,"citationCount":26,"citationInfo":26,"publishDate":1557,"publishYear":1558,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"68409198-a273-4686-aec3-3685e471c6d8","2023-12-12T13:28:10.268+00:00","2025-02-16T07:05:17.772+00:00",[],"Hepatitis-y-embarazo",{"references":1494,"title":1496,"doi":1498},{"VOID":1495},"Bernuau J. Foie et grossesse. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-045-E-10, 2008.\nFagan, 2002, Disorders of the liver, biliary system and pancreas, 282\nBacq, 1996, Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls, Hepatology, 23, 1030, 10.1002\u002Fhep.510230514\nHay, 2008, Liver disease in pregnancy, Hepatology, 47, 1067, 10.1002\u002Fhep.22130\nDucarme, 2010, Foie et prééclampsie, Ann Fr Anesth Reanim, 29, e97, 10.1016\u002Fj.annfar.2010.02.024\nHammoud, 2013, Liver diseases in pregnancy: liver transplantation in pregnancy, World J Gastroenterol, 19, 7647, 10.3748\u002Fwjg.v19.i43.7647\nLazzarotto, 2011, Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy, Clin Microbiol Infect, 17, 1285, 10.1111\u002Fj.1469-0691.2011.03564.x\nPham, 2001, Infections maternofœtales et hépatites virales, 13\nLicata, 2015, Clinical course and management of acute and chronic viral hepatitis during pregnancy, J Viral Hepat, 22, 515, 10.1111\u002Fjvh.12335\nRac, 2014, Prevention and management of viral hepatitis in pregnancy, Obstet Gynecol Clin North Am, 41, 573, 10.1016\u002Fj.ogc.2014.08.004\nElinav, 2006, Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor, Gastroenterology, 130, 1129, 10.1053\u002Fj.gastro.2006.01.007\nWorkowski, 2010, Sexually transmitted diseases treatment guidelines, 2010, MMWR Recomm Rep Morb Mortal Wkly, 59, 1\nMotte, 2009, Acute hepatitis A in a pregnant woman at delivery, Int J Infect Dis, 13, e49, 10.1016\u002Fj.ijid.2008.06.009\nDaudi, 2012, Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection, Breastfeed Med, 7, 313, 10.1089\u002Fbfm.2011.0084\nLeikin, 1996, Intrauterine transmission of hepatitis A virus, Obstet Gynecol, 88, 690, 10.1016\u002F0029-7844(96)00259-1\nFiore, 2003, Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose, Pediatr Infect Dis J, 22, 354, 10.1097\u002F01.inf.0000059446.52063.b9\nDuff, 1998, Hepatitis A vaccine: ready for prime time, Obstet Gynecol, 91, 468, 10.1016\u002FS0029-7844(97)00669-8\nConnell, 2011, Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes, Liver Int, 31, 1163, 10.1111\u002Fj.1478-3231.2011.02556.x\nFan, 2014, Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load, Obstet Gynecol, 123, 929, 10.1097\u002FAOG.0000000000000124\nBacq, 2008, Hépatite virale B et grossesse, Gastroenterol Clin Biol, 32, S12, 10.1016\u002FS0399-8320(08)73260-3\nPiratvisuth, 2013, Optimal management of HBV infection during pregnancy, Liver Int, 33, 188, 10.1111\u002Fliv.12060\nShi, 2010, Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis, Obstet Gynecol, 116, 147, 10.1097\u002FAOG.0b013e3181e45951\nDeng, 2012, The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis, Virol J, 9, 185, 10.1186\u002F1743-422X-9-185\nThe Antiretroviral Pregancy Registry Interim Report for 1 January 1989 through 31 July 2011. Available at www.apregistry.com\u002Fforms\u002Finterim_report.pdf.\nPan, 2012, An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus, Clin Gastroenterol Hepatol, 10, 452, 10.1016\u002Fj.cgh.2011.10.041\nGreenup, 2014, Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus, J Hepatol, 61, 502, 10.1016\u002Fj.jhep.2014.04.038\nWang, 2002, Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis, Chin Med J, 115, 1510\nPan, 2013, Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants, Clin Gastroenterol Hepatol, 11, 1349, 10.1016\u002Fj.cgh.2013.04.026\nShi, 2011, Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review, Arch Pediatr Adolesc Med, 165, 837, 10.1001\u002Farchpediatrics.2011.72\nBzowej, 2012, Optimal management of the hepatitis B patient who desires pregnancy or is pregnant, Curr Hepat Rep, 11, 82, 10.1007\u002Fs11901-012-0130-x\nMirochnick, 2009, Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy, Antimicrob Agents Chemother, 53, 1170, 10.1128\u002FAAC.01117-08\nMast, 2005, A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents, MMWR Recomm Rep Morb Mortal Wkly, 54, 1\nBernard, 2005, Sérologie des hépatites B et C : interprétation et conséquences pratiques chez la femme, Gynecol Obstet Fertil, 33, 423, 10.1016\u002Fj.gyobfe.2005.04.023\nChang, 2007, Hepatitis B virus infection, Semin Fetal Neonatal Med, 12, 160, 10.1016\u002Fj.siny.2007.01.013\nBosch, 2005, Epidemiology of hepatocellular carcinoma, Clin Liver Dis, 9, 191, 10.1016\u002Fj.cld.2004.12.009\nDirection générale de la santé. Comité technique des vaccinations. www.inpes.sante.fr\u002F10000\u002Fthemes\u002Fvaccination\u002Fguide-vaccination-2012\u002Fpdf\u002FGuideVaccinations2012_Vaccination_contre_hepatite_B.pdf.\nHernán, 2004, Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study, Neurology, 63, 838, 10.1212\u002F01.WNL.0000138433.61870.82\nMikaeloff, 2007, Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination, Brain J Neurol, 130, 1105, 10.1093\u002Fbrain\u002Fawl368\nMikaeloff, 2007, Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis, Arch Pediatr Adolesc Med, 161, 1176, 10.1001\u002Farchpedi.161.12.1176\nRehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol, 5, 215, 10.1038\u002Fnri1573\nMast, 2005, Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy, J Infect Dis, 192, 1880, 10.1086\u002F497701\nPergam, 2008, Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort, Am J Obstet Gynecol, 199, 10.1016\u002Fj.ajog.2008.03.052\nSalemi, 2014, Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes, J Viral Hepat, 21, e144, 10.1111\u002Fjvh.12250\nChutaputti, 2000, Adverse effects and other safety aspects of the hepatitis C antivirals, J Gastroenterol Hepatol, 15, E156, 10.1046\u002Fj.1440-1746.2000.02114.x\nDe Clercq, 2007, The design of drugs for HIV and HCV, Nat Rev Drug Discov, 6, 1001, 10.1038\u002Fnrd2424\nMcMenamin, 2008, Obstetric management of hepatitis C-positive mothers: analysis of vertical transmission in 559 mother-infant pairs, Am J Obstet Gynecol, 199, 10.1016\u002Fj.ajog.2008.05.021\nGhamar Chehreh, 2011, Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+\u002FHIV- mothers: a meta-analysis, Arch Gynecol Obstet, 283, 255, 10.1007\u002Fs00404-010-1588-9\nGibb, 2000, Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission, Lancet, 356, 904, 10.1016\u002FS0140-6736(00)02681-7\nTovo, 1997, Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children, Clin Infect Dis, 25, 1121, 10.1086\u002F516102\nResti, 1998, Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection, Br Med J, 317, 437, 10.1136\u002Fbmj.317.7156.437\nHepatitis C virus infection. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics 1998;101:481–5.\nThomas, 1998, A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection, Int J Epidemiol, 27, 108, 10.1093\u002Fije\u002F27.1.108\nPurcell, 2008, Hepatitis E: an emerging awareness of an old disease, J Hepatol, 48, 494, 10.1016\u002Fj.jhep.2007.12.008\nWedemeyer, 2012, Pathogenesis and treatment of hepatitis E virus infection, Gastroenterology, 142, 1388, 10.1053\u002Fj.gastro.2012.02.014\nPrice, 2014, An update on hepatitis B, D, and E viruses, Top Antivir Med, 21, 157\nPatra, 2007, Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection, Ann Intern Med, 147, 28, 10.7326\u002F0003-4819-147-1-200707030-00005\nPal, 2005, Immunological alterations in pregnant women with acute hepatitis E, J Gastroenterol Hepatol, 20, 1094, 10.1111\u002Fj.1440-1746.2005.03875.x\nRenou, 2008, A national survey of acute hepatitis E in France, Aliment Pharmacol Ther, 27, 1086, 10.1111\u002Fj.1365-2036.2008.03679.x\nSclair, 2013, An update on the hepatitis E virus, Curr Gastroenterol Rep, 15, 304, 10.1007\u002Fs11894-012-0304-2\nShinde, 2014, Clinical profile, maternal and fetal outcomes of acute hepatitis E in pregnancy, Ann Med Health Sci Res, 4, S133, 10.4103\u002F2141-9248.138033\nSultana, 2014, Fetomaternal outcome in acute hepatitis E, J Coll Physicians Surg Pak, 24, 127\nAggarwal, 2011, Hepatitis E, Hepatology, 54, 2218, 10.1002\u002Fhep.24674\nKrain, 2014, Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection, Am J Trop Med Hyg, 90, 365, 10.4269\u002Fajtmh.13-0265\nLabrique, 2012, Hepatitis E, a vaccine-preventable cause of maternal deaths, Emerg Infect Dis, 18, 1401, 10.3201\u002Feid1809.120241\nNorvell, 2007, Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases, Liver Transplant, 13, 1428, 10.1002\u002Flt.21250\nBrown, 1997, The acquisition of herpes simplex virus during pregnancy, N Engl J Med, 337, 509, 10.1056\u002FNEJM199708213370801\nBrown, 2006, Maternal herpes simplex virus antibody avidity and risk of neonatal herpes, Am J Obstet Gynecol, 195, 115, 10.1016\u002Fj.ajog.2006.02.013\nStephenson-Famy, 2014, Herpes simplex virus infection during pregnancy, Obstet Gynecol Clin North Am, 41, 601, 10.1016\u002Fj.ogc.2014.08.006\nACOG Committee on Practice Bulletins, 2007, ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy, Obstet Gynecol, 109, 1489\nHollier, 2008, Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection, Cochrane Database Syst Rev, CD004946\nPatel, 2011, European guideline for the management of genital herpes, 2010, Int J STD AIDS, 22, 1, 10.1258\u002Fijsa.2010.010278\nGriffiths, 2015, The pathogenesis of human cytomegalovirus, J Pathol, 235, 288, 10.1002\u002Fpath.4437\nJacquemard, 2007, Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection, BJOG, 114, 1113, 10.1111\u002Fj.1471-0528.2007.01308.x\nNigro, 2005, Passive immunization during pregnancy for congenital cytomegalovirus infection, N Engl J Med, 353, 1350, 10.1056\u002FNEJMoa043337\nOuwendijk, 2015, Pathogenesis of varicelloviruses in primates, J Pathol, 235, 298, 10.1002\u002Fpath.4451\nHeininger, 2006, Varicella, Lancet, 368, 1365, 10.1016\u002FS0140-6736(06)69561-5\nCharlier, 2014, Varicelle, zona et grossesse, Presse Med, 43, 665, 10.1016\u002Fj.lpm.2014.04.001\nBorgia, 2012, Hepatitis B in pregnancy, World J Gastroenterol, 18, 4677, 10.3748\u002Fwjg.v18.i34.4677\nEuropean Association For The Study Of The Liver, 2012, EASL clinical practice guidelines: management of chronic hepatitis B virus infection, J Hepatol, 57, 167, 10.1016\u002Fj.jhep.2012.02.010\nBzowej, 2010, Hepatitis B therapy in pregnancy, Curr Hepat Rep, 9, 197, 10.1007\u002Fs11901-010-0059-x\nDel Canho, 1997, Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity, Vaccine, 15, 1624, 10.1016\u002FS0264-410X(97)00080-7\nHan, 2011, A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus, World J Gastroenterol, 17, 4321, 10.3748\u002Fwjg.v17.i38.4321\nVan Zonneveld, 2003, Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection, J Viral Hepat, 10, 294, 10.1046\u002Fj.1365-2893.2003.00440.x\nXu, 2009, Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study, J Viral Hepat, 16, 94, 10.1111\u002Fj.1365-2893.2008.01056.x\nHan, 2011, A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection, J Hepatol, 55, 1215, 10.1016\u002Fj.jhep.2011.02.032\nSu, 2004, Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy, World J Gastroenterol, 10, 910, 10.3748\u002Fwjg.v10.i6.910\nRawal, 1991, Symptomatic reactivation of hepatitis B in pregnancy, Lancet, 337, 364, 10.1016\u002F0140-6736(91)90993-Y\nTer Borg, 2008, Exacerbation of chronic hepatitis B infection after delivery, J Viral Hepat, 15, 37\nBenaboud, 2011, Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d’Ivoire, in the ANRS 12109 TEmAA Study, Step 2, Antimicrob Agents Chemother, 55, 1315, 10.1128\u002FAAC.00514-10\nHughes, 2011, Hepatitis delta virus, Lancet, 378, 73, 10.1016\u002FS0140-6736(10)61931-9\nRapport de prise en charge des hépatites en 2014 disponible sur www.sante.gouv.fr\u002FIMG\u002Fpdf\u002FRapport_Prise_en_charge_Hepatites_2014.pdf.\nBerkley, 2008, Chronic hepatitis C in pregnancy, Obstet Gynecol, 112, 304, 10.1097\u002FAOG.0b013e318180a4f3\nYeung, 2001, Mother-to-infant transmission of hepatitis C virus, Hepatology, 34, 223, 10.1053\u002Fjhep.2001.25885\nJalan, 2006, Paracetamol: are therapeutic doses entirely safe?, Lancet, 368, 2195, 10.1016\u002FS0140-6736(06)69874-7\nBernuau, 2004, Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain, J Hepatol, 41, 152, 10.1016\u002Fj.jhep.2004.05.007\nLassi, 2014, Essential pre-pregnancy and pregnancy interventions for improved maternal, newborn and child health, Reprod Health, 11, S2\nMuehlenbachs, 2006, Hypertension and maternal-fetal conflict during placental malaria, PLoS Med, 3, e446, 10.1371\u002Fjournal.pmed.0030446\nKnox, 1996, Liver disease in pregnancy, N Engl J Med, 335, 569, 10.1056\u002FNEJM199608223350807\nHelbok, 2005, The use of the multi-organ-dysfunction score to discriminate different levels of severity in severe and complicated Plasmodium falciparum malaria, Am J Trop Med Hyg, 72, 150, 10.4269\u002Fajtmh.2005.72.150\nViriyavejakul, 2014, Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression, Malar J, 13, 106, 10.1186\u002F1475-2875-13-106\nTournoy, 2006, Haemolysis, elevated liver enzymes, and thrombocytopenia in a 34-year-old pregnant woman, Lancet, 368, 90, 10.1016\u002FS0140-6736(06)68973-3\nAgboghoroma, 2014, Current management and prevention of malaria in pregnancy: a review, West Afr J Med, 33, 91\nVisser, 2014, Malaria: an update on current chemotherapy, Expert Opin Pharmacother, 15, 2219, 10.1517\u002F14656566.2014.944499\nDziri, 2004, Treatment of hydatid cyst of the liver: where is the evidence?, World J Surg, 28, 731, 10.1007\u002Fs00268-004-7516-z\nMontes, 2002, Hydatid disease in pregnancy, Am J Gastroenterol, 97, 1553, 10.1111\u002Fj.1572-0241.2002.05742.x\nRodrigues, 2008, Management of hydatid disease (echinococcosis) in pregnancy, Obstet Gynecol Surv, 63, 116, 10.1097\u002FOGX.0b013e3181601766\nBhattacharyya, 2013, Dilemmas encountered while dealing a pregnancy complicated by pelvic hydatid disease, Arch Gynecol Obstet, 288, 965, 10.1007\u002Fs00404-013-2859-z\n2003, 1\nBeyens, 2003, Prescription of drugs to pregnant women in France: the HIMAGE study, Therapie, 58, 505, 10.2515\u002Ftherapie:2003082\nManns, 2001, Autoimmune hepatitis: clinical challenges, Gastroenterology, 120, 1502, 10.1053\u002Fgast.2001.24227\nBen-Ari, 2001, Autoimmune hepatitis and its variant syndromes, Gut, 49, 589, 10.1136\u002Fgut.49.4.589\nCarson, 2003, Autoimmune hepatitis: diagnosis after preeclampsia-induced elevated liver enzymes failed to normalize postpartum, Obstet Gynecol, 101, 1118\nSchramm, 2006, Pregnancy in autoimmune hepatitis: outcome and risk factors, Am J Gastroenterol, 101, 556, 10.1111\u002Fj.1572-0241.2006.00479.x\nHeneghan, 2001, Management and outcome of pregnancy in autoimmune hepatitis, Gut, 48, 97, 10.1136\u002Fgut.48.1.97\nTanaka, 2002, Autoimmune hepatitis complicated with antiphospholipid syndrome in pregnancy, Am J Reprod Immunol, 47, 142, 10.1034\u002Fj.1600-0897.2002.1c082.x\nLiaskos, 2005, Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis, J Autoimmun, 24, 251, 10.1016\u002Fj.jaut.2005.01.016\nGhandour, 1998, Immunosuppressive drugs in pregnancy, Adv Ren Replace Ther, 5, 31, 10.1016\u002FS1073-4449(98)70012-3\nRivoire, 2008, Hépatite auto-immune et grossesse : à propos de trois grossesses consécutives chez une patiente, Gynecol Obstet Fertil, 36, 299, 10.1016\u002Fj.gyobfe.2007.07.044",{"ES":1497},"Hepatitis y embarazo",{"VOID":1499},"10.1016\u002Fs1283-081x(16)77884-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X16778842",[1502,1517,1529],{"id":1503,"sortIndex":36,"researcher":26,"roles":1504,"affiliations":1505,"properties":1514},"97c83ae5-b748-4878-a263-815868486f45",[696],[1506],{"id":26,"sortIndex":36,"affiliation":1507,"properties":26},{"id":1508,"createTime":1509,"updateTime":1509,"relativeEntities":1510,"slug":26,"properties":1511,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b81239a6-b1c5-4ee0-956b-70f53fee4aa1","2023-12-12T13:28:10.294+00:00",[],{"title":1512},{"VI":1513},"Service de gynécologie-obstétrique, Centre hospitalier départemental, 85000 La Roche-sur-Yon, France",{"title":1515},{"VI":1516},"G. Ducarme",{"id":1518,"sortIndex":114,"researcher":26,"roles":1519,"affiliations":1520,"properties":1526},"bc64a18d-2e94-4928-9c74-7a52e55b405c",[696],[1521],{"id":26,"sortIndex":36,"affiliation":1522,"properties":26},{"id":1508,"createTime":1509,"updateTime":1509,"relativeEntities":1523,"slug":26,"properties":1524,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1525},{"VI":1513},{"title":1527},{"VI":1528},"V. Dochez",{"id":1530,"sortIndex":115,"researcher":26,"roles":1531,"affiliations":1532,"properties":1541},"94c3f3a1-08a8-4a10-9847-c5629bfb383a",[696],[1533],{"id":26,"sortIndex":36,"affiliation":1534,"properties":26},{"id":1535,"createTime":1536,"updateTime":1536,"relativeEntities":1537,"slug":26,"properties":1538,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c6cc543b-4d67-4b9e-a6e5-11d72100263b","2023-12-12T13:27:54.988+00:00",[],{"title":1539},{"VI":1540},"Service d’hépato-gastro-entérologie, Centre hospitalier départemental, 85000 La Roche-sur-Yon, France",{"title":1542},{"VI":1543},"M. Schnee",{"url":1500,"publisher":1545,"properties":1553},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1546,"slug":662,"properties":1547,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1550,"manageAffiliations":1551,"indexDatabases":1552,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1548,"title":1549},{"VOID":665},{"EN":667},[],[],[],{"volume":1554,"pages":1556},{"VOID":1555},"52",{"VOID":761},"2016-06-01",2016]